UvA-DARE (Digital Academic Repository)

Antidepressants and the adolescent brain: Changing the course of neurodevelopment?

Klomp, A.

Publication date 2013

Link to publication

Citation for published version (APA): Klomp, A. (2013). Antidepressants and the adolescent brain: Changing the course of neurodevelopment?. Boxpress.

General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

Download date:29 Sep 2021 References

233 Appendix

‘t Jong, G.W., van der Linden, P.D., Bakker, E.M., van Anand, A., Li, Y., Wang, Y., Wu, J., Gao, S., Bukhari, der Lely, N., Eland, I.A., Stricker, B.H., van den L., Mathews, V.P., Kalnin, A., Lowe, M.J., 2005. Anker, J.N., 2002. Unlicensed and off-label drug Antidepressant effect on connectivity of use in a paediatric ward of a general hospital in the the mood-regulating circuit: an FMRI study. Netherlands. Eur.J.Clin.Pharmacol. 58, 293-297. Neuropsychopharmacology 30, 1334-1344.

Abramoff, M.D., Magelhaes P.J., Ram, S.J., 2004. Image Andersen, C.L., Jensen, J.L., Orntoft, T.F., 2004. Processing with ImageJ. 11 ed, pp. 36-42. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance Adriani, W., Laviola, G., 2004. Windows of vulnerability estimation approach to identify genes suited for to psychopathology and therapeutic strategy in the normalization, applied to bladder and colon cancer adolescent rodent model. Behav.Pharmacol. 15, data sets. Cancer Res. 64, 5245-5250. 341-352. Andersen, S.L., 2003. Trajectories of brain development: Adriani, W., Leo, D., Guarino, M., Natoli, A., Di Consiglio, point of vulnerability or window of opportunity? E., De Angelis, G., Traina, E., Testai, E., Perrone- Neurosci.Biobehav.Rev. 27, 3-18. Capano, C., Laviola, G., 2006. Short-term effects of adolescent methylphenidate exposure on brain Andersen, S.L., 2005. Stimulants and the developing striatal gene expression and sexual/endocrine brain. Trends Pharmacol.Sci. 26, 237-243. parameters in male rats. Ann.N.Y.Acad.Sci. 1074, 52- Andersen, S.L., Navalta, C.P., 2004. Altering the course of 73. neurodevelopment: a framework for understanding Aguirre, G.K., Zarahn, E., D’Esposito, M., 1998a. The the enduring effects of psychotropic drugs. Int.J Dev. variability of human, BOLD hemodynamic responses. Neurosci 22, 423-440. NeuroImage 8, 360-369. Andersen, S.L., Navalta, C.P., 2011. Annual Research Aguirre, N., Barrionuevo, M., Lasheras, B., Del Review: New frontiers in developmental Rio, J., 1998b. The role of dopaminergic neuropharmacology: can long-term therapeutic systems in the perinatal sensitivity to 3, effects of drugs be optimized through carefully 4-methylenedioxymethamphetamine-induced timed early intervention? J.Child Psychol.Psychiatry neurotoxicity in rats. J.Pharmacol.Exp.Ther. 286, 52, 476-503. 1159-1165. Andersen, S.L., Teicher, M.H., 2008. Stress, sensitive Alex, K.D., Pehek, E.A., 2007. Pharmacologic periods and maturational events in adolescent mechanisms of serotonergic regulation of dopamine depression. Trends Neurosci. 31, 183-191. neurotransmission. Pharmacol.Ther. 113, 296-320. Anderson, I.M., Del-Ben, C.M., McKie, S., Richardson, Alwan, S., Friedman, J.M., 2009. Safety of selective P., Williams, S.R., Elliott, R., Deakin, J.F., 2007. serotonin reuptake inhibitors in pregnancy. CNS. Citalopram modulation of neuronal responses to Drugs 23, 493-509. aversive face emotions: a functional MRI study. Neuroreport 18, 1351-1355. Amargos-Bosch, M., Artigas, F., Adell, A., 2005. Effects of acute olanzapine after sustained fluoxetine on Anderson, I.M., Juhasz, G., Thomas, E., Downey, D., extracellular monoamine levels in the rat medial McKie, S., Deakin, J.F., Elliott, R., 2011a. The effect prefrontal cortex. Eur.J.Pharmacol. 516, 235-238. of acute citalopram on face emotion processing in remitted depression: a pharmacoMRI study. Eur. American Psychiatric Association, 1994. Diagnostic and Neuropsychopharmacol. 21, 140-148. statistical manual of mental health disorders, 4th ed. American Psychiatric Association, Washington DC. Anderson, I.M., McKie, S., Elliott, R., Williams, S.R., Deakin, J.F., 2008. Assessing human 5-HT function Amico, F., Stauber, J., Koutsouleris, N., Frodl, T., 2011. in vivo with pharmacoMRI. Neuropharmacology 55, Anterior cingulate cortex gray matter abnormalities 1029-1037. in adults with attention deficit hyperactivity disorder: a voxel-based morphometry study. Psychiatry Res. 191, 31-35.

234 References

Anderson, I.M., Shippen, C., Juhasz, G., Chase, D., Barbon, A., Popoli, M., La Via, L., Moraschi, S., Vallini, Thomas, E., Downey, D., Toth, Z.G., Lloyd-Williams, I., Tardito, D., Tiraboschi, E., Musazzi, L., Giambelli, K., Elliott, R., Deakin, J.F., 2011b. State-dependent R., Gennarelli, M., Racagni, G., Barlati, S., 2006. alteration in face emotion recognition in depression. Regulation of editing and expression of glutamate Br.J.Psychiatry 198, 302-308. alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol.Psychiatry Andersson, A., Sundman, I., Marcusson, J., 1992. Age 59, 713-720. stability of human brain 5-HT terminals studied with [3H]paroxetine binding. Gerontology 38, 127-132. Bastos, E.F., Marcelino, J.L., Amaral, A.R., Serfaty, C.A., 1999. Fluoxetine-induced plasticity in the rodent Arranz, B., Eriksson, A., Mellerup, E., Plenge, P., visual system. Brain Res. 824, 28-35. Marcusson, J., 1993. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Battaglia, G., Yeh, S.Y., O’Hearn, E., Molliver, Res. 620, 163-166. M.E., Kuhar, M.J., De Souza, E.B., 1987. 3,4-Methylenedioxymethamphetamine and Ashburner, J., 2007. A fast diffeomorphic image 3,4-methylenedioxyamphetamine destroy registration algorithm. Neuroimage. 38, 95-113. serotonin terminals in rat brain: quantification Azmitia, E.C., 2001. Modern views on an ancient of neurodegeneration by measurement of [3H] chemical: serotonin effects on cell proliferation, paroxetine-labeled serotonin uptake sites. maturation, and apoptosis. Brain Res.Bull. 56, 413- J.Pharmacol.Exp.Ther. 242, 911-916. 424. Beasley, C.M., Nilsson, M.E., Koke, S.C., Gonzales, Azmitia, E.C., Murphy, R.B., Whitaker-Azmitia, J.S., 2000. Efficacy, adverse events, and treatment P.M., 1990. MDMA (ecstasy) effects on cultured discontinuations in fluoxetine clinical studies of serotonergic neurons: evidence for Ca2(+)- major depression: a meta-analysis of the 20-mg/day dependent toxicity linked to release. Brain Res. 510, dose. J Clin Psychiatry 61, 722-728. 97-103. Beck, A.T., Epstein, N., Brown, G., Steer, R.A., 1988. Aznavour, N., Rbah, L., Riad, M., Reilhac, A., Costes, An inventory for measuring clinical anxiety: N., Descarries, L., Zimmer, L., 2006. A PET imaging psychometric properties. J.Consult Clin.Psychol. 56, study of 5-HT(1A) receptors in cat brain after acute 893-897. and chronic fluoxetine treatment. Neuroimage. 33, Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., 834-842. Erbauch, J., 1961. An inventory for measuring Bachrach, L.K., 2004. Bare-bones fact--children are not depression. Arch.Gen.Psychiatry 4, 561-571. small adults. N.Engl.J.Med. 351, 924-926. Ben Bashat, D., Ben Sira, L., Graif, M., Pianka, P., Hendler, Balu, D.T., 2010. Enhanced sensitivity of the MRL/MpJ T., Cohen, Y., Assaf, Y., 2005. Normal white matter mouse to the neuroplastic and behavioral effects of development from infancy to adulthood: comparing acute and chronic antidepressant treatments. Exp. diffusion tensor and high b value diffusion weighted Clin.Psychopharmacol. 18, 71-77. MR images. J.Magn Reson.Imaging 21, 503-511.

Banasr, M., Hery, M., Printemps, R., Daszuta, A., Benes, F.M., Taylor, J.B., Cunningham, M.C., 2000. 2004. Serotonin-induced increases in adult cell Convergence and plasticity of monoaminergic proliferation and neurogenesis are mediated systems in the medial prefrontal cortex during the through different and common 5-HT receptor postnatal period: implications for the development subtypes in the dentate gyrus and the subventricular of psychopathology. Cereb.Cortex 10, 1014-1027. zone. Neuropsychopharmacology 29, 450-460. Benmansour, S., Cecchi, M., Morilak, D.A., Gerhardt, Bao, A.M., Meynen, G., Swaab, D.F., 2008. The stress G.A., Javors, M.A., Gould, G.G., Frazer, A., 1999. system in depression and neurodegeneration: focus Effects of Chronic Antidepressant Treatments on on the human hypothalamus. Brain Res.Rev. 57, 531- Serotonin Transporter Function, Density, and mRNA 553. Level. Journal of Neuroscience 19, 10494-10501. & 235 Appendix

Benninghoff, J., van der Ven, A., Schloesser, R.J., Blier, P., de Montigny, C., 1999. Serotonin and drug- Moessner, R., Moller, H.J., Rujescu, D., 2012. The induced therapeutic responses in major depression, complex role of the serotonin transporter in adult obsessive-compulsive and panic disorders. neurogenesis and neuroplasticity. A critical review. Neuropsychopharmacology 21, 91S-98S. World J.Biol.Psychiatry 13, 240-247. Bock, N., Quentin, D.J., Huther, G., Moll, G.H., Berton, O., Hahn, C.G., Thase, M.E., 2012. Are we Banaschewski, T., Rothenberger, A., 2005. Very early getting closer to valid translational models for major treatment with fluoxetine and reboxetine causing depression? Science 338, 75-79. long-lasting change of the serotonin but not the noradrenaline transporter in the frontal cortex of Best, J., Nijhout, H.F., Reed, M., 2010. Serotonin rats. World J Biol.Psychiatry 6, 107-112. synthesis, release and reuptake in terminals: a mathematical model. Theor.Biol.Med.Model. 7, 34. Boileau, I., Dagher, A., Leyton, M., Gunn, R.N., Baker, G.B., Diksic, M., Benkelfat, C., 2006. Modeling Beyer, C.E., Cremers, T.I., 2008. Do selective serotonin sensitization to stimulants in humans: an [11C] reuptake inhibitors acutely increase frontal cortex raclopride/positron emission tomography study in levels of serotonin? Eur.J.Pharmacol. 580, 350-354. healthy men. Arch.Gen.Psychiatry 63, 1386-1395. Bhagwagar, Z., Cowen, P.J., 2008. ‘It’s not over when Bolanos, C.A., Barrot, M., Berton, O., Wallace-Black, it’s over’: persistent neurobiological abnormalities D., Nestler, E.J., 2003. Methylphenidate treatment in recovered depressed patients. Psychol.Med. 38, during pre- and periadolescence alters behavioral 307-313. responses to emotional stimuli at adulthood. Biol. Bhansali, P., Dunning, J., Singer, S.E., David, L., Schmauss, Psychiatry 54, 1317-1329. C., 2007. Early life stress alters adult serotonin 2C Boldrini, M., Hen, R., Underwood, M.D., Rosoklija, receptor pre-mRNA editing and expression of the G.B., Dwork, A.J., Mann, J.J., Arango, V., 2012. alpha subunit of the heterotrimeric G-protein G q. J Hippocampal angiogenesis and progenitor cell Neurosci 27, 1467-1473. proliferation are increased with antidepressant use Bigos, K.L., Pollock, B.G., Aizenstein, H.J., Fisher, P.M., in major depression. Biol.Psychiatry 72, 562-571. Bies, R.R., Hariri, A.R., 2008. Acute 5-HT Reuptake Boldrini, M., Underwood, M.D., Hen, R., Rosoklija, Blockade Potentiates Human Amygdala Reactivity. G.B., Dwork, A.J., John, M.J., Arango, V., 2009. Neuropsychopharmacology 33, 3221-3225. Antidepressants increase neural progenitor cells in the Birmaher, B., Khetarpal, S., Brent, D., Cully, M., Balach, human hippocampus. Neuropsychopharmacology L., Kaufman, J., Neer, S.M., 1997. The Screen for Child 34, 2376-2389. Anxiety Related Emotional Disorders (SCARED): scale Bonefeld, B.E., Elfving, B., Wegener, G., 2008. Reference construction and psychometric characteristics. J.Am. genes for normalization: a study of rat brain tissue. Acad.Child Adolesc.Psychiatry 36, 545-553. Synapse 62, 302-309. Birmaher, B., Ryan, N.D., Williamson, D.E., Brent, D.A., Booij, J., Bergmans, P., Winogrodzka, A., Speelman, Kaufman, J., Dahl, R.E., Perel, J., Nelson, B., 1996. J.D., Wolters, E.C., 2001. Imaging of dopamine Childhood and adolescent depression: a review of transporters with [123I]FP-CIT SPECT does not the past 10 years. Part I. J.Am.Acad.Child Adolesc. suggest a significant effect of age on the symptomatic Psychiatry 35, 1427-1439. threshold of disease in Parkinson’s disease. Synapse Blakemore, S.J., 2008. The social brain in adolescence. 39, 101-108. Nat.Rev Neurosci 9, 267-277. Booij, J., Tissingh, G., Boer, G.J., Speelman, J.D., Stoof, Bland, J.M., Altman, D.G., 1996. Measurement error. J.C., Janssen, A.G., Wolters, E.C., Van Royen, E.A., BMJ 313, 744. 1997. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling Blier, P., 2001. Pharmacology of rapid-onset in early and advanced Parkinson’s disease. J.Neurol. antidepressant treatment strategies. J.Clin. Neurosurg.Psychiatry 62, 133-140. Psychiatry 62 Suppl 15, 12-17.

236 References

Borue, X., Chen, J., Condron, B.G., 2007. Developmental antidepressant treatment: a meta-analysis of effects of SSRIs: lessons learned from animal studies. randomized controlled trials. JAMA: The Journal of Int.J Dev.Neurosci 25, 341-347. the American Medical Association 297, 1683-1696.

Bossers, K., Meerhoff, G., Balesar, R., van Dongen, Broening, H.W., Bacon, L., Slikker, W. Jr., 1994. J.W., Kruse, C.G., Swaab, D.F., Verhaagen, J., 2009. Age modulates the long-term but not the Analysis of gene expression in Parkinson’s disease: acute effects of the serotonergic neurotoxicant possible involvement of neurotrophic support and 3,4-methylenedioxymethamphetamine. axon guidance in dopaminergic cell death. Brain J.Pharmacol.Exp.Ther. 271, 285-293. Pathol. 19, 91-107. Brunello, N., Riva, M., Volterra, A., Racagni, G., 1985. Bouet, V., Freret, T., Ankri, S., Bezault, M., Renolleau, S., Age-related changes in 5HT uptake and [3H] Boulouard, M., Jacotot, E., Chauvier, D., Schumann- imipramine binding sites in rat cerebral cortex. Bard, P., 2010. Predicting sensorimotor and Eur.J.Pharmacol. 110, 393-394. memory deficits after neonatal ischemic stroke with Buckner, R.L., Andrews-Hanna, J.R., Schacter, D.L., 2008. reperfusion in the rat. Behav.Brain Res. 212, 56-63. The brain’s default network: anatomy, function, and Bouet, V., Klomp, A., Freret, T., Wylezinska-Arridge, relevance to disease. Ann.N.Y.Acad.Sci. 1124, 1-38. M., Lopez-Tremoleda, J., Dauphin, F., Boulouard, Burd, L., Klug, M.G., Coumbe, M.J., Kerbeshian, J., 2003. M., Booij, J., Gsell, W., Reneman, L., 2012. Age- Children and adolescents with attention deficit- dependent effects of chronic fluoxetine treatment hyperactivity disorder: 1. Prevalence and cost of on the serotonergic system one week following care. J.Child Neurol. 18, 555-561. treatment. Psychopharmacology (Berl) 221, 329- 339. Burnet, P.W., Michelson, D., Smith, M.A., Gold, P.W., Sternberg, E.M., 1994. The effect of chronic Bourdeaux, R., Desor, D., Lehr, P.R., Younos, C., imipramine administration on the densities of Capolaghi, B., 1998. Effects of fluoxetine and 5-HT1A and 5-HT2 receptors and the abundances of norfluoxetine on 5-hydroxytryptamine metabolism 5-HT receptor and transporter mRNA in the cortex, in blood platelets and brain after administration to hippocampus and dorsal raphe of three strains of rats. J Pharm.Pharmacol 50, 1387-1392. rat. Brain Res. 638, 311-324. Boylan, C.B., Bennett-Clarke, C.A., Chiaia, N.L., Rhoades, Bymaster, F.P., Zhang, W., Carter, P.A., Shaw, J., R.W., 2000. Time course of expression and function Chernet, E., Phebus, L., Wong, D.T., Perry, K.W., of the serotonin transporter in the neonatal rat’s 2002. Fluoxetine, but not other selective serotonin primary somatosensory cortex. Somatosens.Mot. uptake inhibitors, increases norepinephrine and Res. 17, 52-60. dopamine extracellular levels in prefrontal cortex. Boyle, C.A., Boulet, S., Schieve, L.A., Cohen, R.A., Psychopharmacology (Berl) 160, 353-361. Blumberg, S.J., Yeargin-Allsopp, M., Visser, S., Caballero, J., Nahata, M.C., 2005. Selective serotonin- Kogan, M.D., 2011. Trends in the prevalence of reuptake inhibitors and suicidal ideation and developmental disabilities in US children, 1997- behavior in children. Am.J.Health Syst.Pharm. 62, 2008. Pediatrics 127, 1034-1042. 864-867. Brenhouse, H.C., Andersen, S.L., 2011. Developmental Cabrera-Vera, T.M., Garcia, F., Pinto, W., Battaglia, G., trajectories during adolescence in males and 1997. Effect of prenatal fluoxetine (Prozac) exposure females: a cross-species understanding of underlying on brain serotonin neurons in prepubescent and brain changes. Neurosci.Biobehav.Rev. 35, 1687- adult male rat offspring. J.Pharmacol.Exp.Ther. 280, 1703. 138-145. Bridge, J.A., Iyengar, S., Salary, C.B., Barbe, R.P., Birmaher, B., Pincus, H.A., Ren, L., Brent, D.A., 2007. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric & 237 Appendix

Caccia, S., Cappi, M., Fracasso, C., Garattini, S., 1990. Chen, Y., Wan, H.I., O’Reardon, J.P., Wang, D.J., Wang, Z., Influence of dose and route of administration Korczykowski, M., Detre, J.A., 2011a. Quantification on the kinetics of fluoxetine and its metabolite of cerebral blood flow as biomarker of drug effect: norfluoxetine in the rat. Psychopharmacology (Berl) arterial spin labeling phMRI after a single dose of 100, 509-514. oral citalopram. Clin.Pharmacol.Ther. 89, 251-258.

Caceres, A., Hall, D.L., Zelaya, F.O., Williams, S.C., Chen, Y., Wang, D.J., Detre, J.A., 2011b. Test-retest Mehta, M.A., 2009. Measuring fMRI reliability with reliability of arterial spin labeling with common the intra-class correlation coefficient. Neuroimage. labeling strategies. J.Magn Reson.Imaging 33, 940- 45, 758-768. 949.

Canli, T., Lesch, K.P., 2007. Long story short: the Cheung, A.H., Emslie, G.J., Mayes, T.L., 2005. Review of serotonin transporter in emotion regulation and the efficacy and safety of antidepressants in youth social cognition. Nat.Neurosci. 10, 1103-1109. depression. J.Child Psychol.Psychiatry 46, 735-754.

Capela, J.P., Carmo, H., Remiao, F., Bastos, M.L., Choi, J.K., Chen, Y.I., Hamel, E., Jenkins, B.G., 2006. Meisel, A., Carvalho, F., 2009. Molecular and cellular Brain hemodynamic changes mediated by dopamine mechanisms of ecstasy-induced neurotoxicity: an receptors: Role of the cerebral microvasculature overview. Mol.Neurobiol. 39, 210-271. in dopamine-mediated neurovascular coupling. Neuroimage. 30, 700-712. Casey, B.J., Jones, R.M., Hare, T.A., 2008. The adolescent brain. Ann N.Y.Acad.Sci. 1124, 111-126. Choi, M.R., Hwang, S., Park, G.M., Jung, K.H., Kim, S.H., Das, N.D., Chai, Y.G., 2012. Effect of fluoxetine Castellanos, F.X., Margulies, D.S., Kelly, C., Uddin, on the expression of tryptophan hydroxylase and L.Q., Ghaffari, M., Kirsch, A., Shaw, D., Shehzad, Z., 14-3-3 protein in the dorsal raphe nucleus and Di, M.A., Biswal, B., Sonuga-Barke, E.J., Rotrosen, hippocampus of rat. J.Chem.Neuroanat. 43, 96-102. J., Adler, L.A., Milham, M.P., 2008. Cingulate- precuneus interactions: a new locus of dysfunction Ciliax, B.J., Heilman, C., Demchyshyn, L.L., Pristupa, in adult attention-deficit/hyperactivity disorder. Biol. Z.B., Ince, E., Hersch, S.M., Niznik, H.B., Levey, A.I., Psychiatry 63, 332-337. 1995. The dopamine transporter: immunochemical characterization and localization in brain. Journal of Castellanos, F.X., Tannock, R., 2002. Neuroscience of Neuroscience 15, 1714-1723. attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat.Rev.Neurosci. 3, 617-628. Cipriani, A., Geddes, J.R., Furukawa, T.A., Barbui, C., 2007. Metareview on short-term effectiveness Castro, J.E., Varea, E., Marquez, C., Cordero, M.I., and safety of antidepressants for depression: an Poirier, G., Sandi, C., 2010. Role of the amygdala evidence-based approach to inform clinical practice. in antidepressant effects on hippocampal cell Can.J.Psychiatry 52, 553-562. proliferation and survival and on depression-like behavior in the rat. PLoS.ONE. 5, e8618. Cizek, L.J., Nocenti, M.R., 1965. Relationship between water and food ingestion in the rat. Am.J.Physiol Cavanna, A.E., Trimble, M.R., 2006. The precuneus: a 208, 615-620. review of its functional anatomy and behavioural correlates. Brain 129, 564-583. Clark, D.B., Kirisci, L., Tarter, R.E., 1998. Adolescent versus adult onset and the development of Chalela, J.A., Alsop, D.C., Gonzalez-Atavales, J.B., substance use disorders in males. Drug Alcohol Maldjian, J.A., Kasner, S.E., Detre, J.A., 2000. Depend. 49, 115-121. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin Clarke, G.N., Lewinsohn, P.M., 1989. The coping with labeling. Stroke 31, 680-687. depression course: a group psychoeducational intervention for unipolar disease. Behavior Change 6, 54-69.

238 References

Cohen, Z., Bonvento, G., Lacombe, P., Hamel, E., 1996. D’Amato, R.J., Blue, M.E., Largent, B.L., Lynch, D.R., Serotonin in the regulation of brain microcirculation. Ledbetter, D.J., Molliver, M.E., Snyder, S.H., Prog.Neurobiol. 50, 335-362. 1987. Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense Colado, M.I., O’Shea, E., Granados, R., Misra, A., Murray, innervation to primary sensory areas. Proc.Natl. T.K., Green, A.R., 1997. A study of the neurotoxic Acad.Sci.U.S.A 84, 4322-4326. effect of MDMA (‘ecstasy’) on 5-HT neurones in the brains of mothers and neonates following Dahlstrom, M., Ahonen, A., Ebeling, H., Torniainen, administration of the drug during pregnancy. P., Heikkila, J., Moilanen, I., 2000. Elevated Br.J.Pharmacol. 121, 827-833. hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive Cornelisse, L.N., Van der Harst, J.E., Lodder, J.C., children and adolescents. Mol.Psychiatry 5, 514-522. Baarendse, P.J., Timmerman, A.J., Mansvelder, H.D., Spruijt, B.M., Brussaard, A.B., 2007. Reduced Dalgaard, L., Larsen, C., 1999. Metabolism and excretion 5-HT1A- and GABAB receptor function in dorsal of citalopram in man: identification of O-acyl- and raphé neurons upon chronic fluoxetine treatment of N-glucuronides. Xenobiotica 29, 1033-1041. socially stressed rats. J.Neurophysiol. 98, 196-204. David, D.J., Samuels, B.A., Rainer, Q., Wang, J.W., Cortese, S., Konofal, E., Lecendreux, M., Arnulf, I., Marsteller, D., Mendez, I., Drew, M., Craig, D.A., Mouren, M.C., Darra, F., Dalla, B.B., 2005. Restless Guiard, B.P., Guilloux, J.P., Artymyshyn, R.P., Gardier, legs syndrome and attention-deficit/hyperactivity A.M., Gerald, C., Antonijevic, I.A., Leonardo, E.D., disorder: a review of the literature. Sleep 28, 1007- Hen, R., 2009. Neurogenesis-dependent and 1013. -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62, 479-493. Couillard-Despres, S., Wuertinger, C., Kandasamy, M., Caioni, M., Stadler, K., Aigner, R., Bogdahn, U., Aigner, Dawson, L.A., Nguyen, H.Q., 2000. The role of 5-HT(1A) L., 2009. Ageing abolishes the effects of fluoxetine and 5-HT(1B/1D) receptors on the modulation of on neurogenesis. Mol.Psychiatry 14, 856-864. acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol. Cowen, D.S., Takase, L.F., Fornal, C.A., Jacobs, B.L., Neuropharmacology 39, 1044-1052. 2008. Age-dependent decline in hippocampal neurogenesis is not altered by chronic treatment de Groote, L., Olivier, B., Westenberg, H.G., 2002. with fluoxetine. Brain Res. 1228, 14-19. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: Crews, F., He, J., Hodge, C., 2007. Adolescent cortical a microdialysis study in knockout mice. development: a critical period of vulnerability for Psychopharmacology (Berl) 162, 419-424. addiction. Pharmacol.Biochem.Behav. 86, 189-199. de Kloet, E.R., Joels, M., Holsboer, F., 2005. Stress and Cruz, D.A., Eggan, S.M., Lewis, D.A., 2003. Postnatal the brain: from adaptation to disease. Nat.Rev. development of pre- and postsynaptic GABA markers Neurosci. 6, 463-475. at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. J.Comp Neurol. de Sousa, A.R., Penalva, L.O., Marcotte, E.M., Vogel, 465, 385-400. C., 2009. Global signatures of protein and mRNA expression levels. Mol.Biosyst. 5, 1512-1526. Cullen, K.R., 2012. Imaging adolescent depression treatment. Am.J.Psychiatry 169, 348-350. de Win, M.M., de Jeu, R.A., de Bruin, K., Habraken, J.B., Reneman, L., Booij, J., den Heeten, G.J., Czeh, B., Lucassen, P.J., 2007. What causes the 2004. Validity of in vivo [123I]beta-CIT SPECT in hippocampal volume decrease in depression? detecting MDMA-induced neurotoxicity in rats. Eur. Are neurogenesis, glial changes and apoptosis Neuropsychopharmacol. 14, 185-189. implicated? Eur.Arch.Psychiatry Clin.Neurosci. 257, 250-260. de Win, M.M., Habraken, J.B., Reneman, L., van den Brink, W., den Heeten, G.J., Booij, J., 2005. Validation of [(123)I]beta-CIT SPECT to assess & 239 Appendix

serotonin transporters in vivo in humans: a double- Duman, R.S., Nakagawa, S., Malberg, J., 2001. blind, placebo-controlled, crossover study with the Regulation of adult neurogenesis by antidepressant selective serotonin reuptake inhibitor citalopram. treatment. Neuropsychopharmacology 25, 836-844. Neuropsychopharmacology 30, 996-1005. Durston, S., Tottenham, N.T., Thomas, K.M., Davidson, de Win, M.M., Reneman, L., Jager, G., Vlieger, E.J., M.C., Eigsti, I.M., Yang, Y., Ulug, A.M., Casey, B.J., Olabarriaga, S.D., Lavini, C., Bisschops, I., Majoie, 2003. Differential patterns of striatal activation C.B., Booij, J., den Heeten, G.J., van den Brink, W., in young children with and without ADHD. Biol. 2007. A prospective cohort study on sustained Psychiatry 53, 871-878. effects of low-dose ecstasy use on the brain in new Dygalo, N.N., Shishkina, G.T., Kalinina, T.S., Yudina, ecstasy users. Neuropsychopharmacology 32, 458- A.M., Ovchinnikova, E.S., 2006. Effect of repeated 470. treatment with fluoxetine on tryptophan Deakin, J.F., 1991. Depression and 5HT. Int.Clin. hydroxylase-2 gene expression in the rat brainstem. Psychopharmacol. 6 Suppl 3, 23-28. Pharmacol.Biochem.Behav. 85, 220-227.

Del-Ben, C.M., Deakin, J.F., McKie, S., Delvai, N.A., Dzirasa, K., Covington III, H.E., 2012. Increasing the Williams, S.R., Elliott, R., Dolan, M., Anderson, validity of experimental models for depression. I.M., 2005. The effect of citalopram pretreatment Ann.N.Y.Acad.Sci. 1265, 36-45. on neuronal responses to neuropsychological Ebmeier, K.P., Donaghey, C., Steele, J.D., 2006. tasks in normal volunteers: an FMRI study. Recent developments and current controversies in Neuropsychopharmacology 30, 1724-1734. depression. Lancet 367, 153-167. Delaveau, P., Jabourian, M., Lemogne, C., Guionnet, Eison, A.S., Mullins, U.L., 1996. Regulation of central S., Bergouignan, L., Fossati, P., 2011. Brain effects 5-HT2A receptors: a review of in vivo studies. Behav. of antidepressants in major depression: a meta- Brain Res. 73, 177-181. analysis of emotional processing studies. J.Affect. Disord. 130, 66-74. Elfving, B., Madsen, J., Knudsen, G.M., 2007. Neuroimaging of the serotonin reuptake site Descarries, L., Riad, M., 2012. Effects of the requires high-affinity ligands. Synapse 61, 882-888. antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT. Philos. Encinas, J.M., Sierra, A., 2012. Neural stem cell Trans.R.Soc.Lond B Biol.Sci. 367, 2416-2425. deforestation as the main force driving the age- related decline in adult hippocampal neurogenesis. DeVane, C.L., 1999. Metabolism and pharmacokinetics Behav.Brain Res. 227, 433-439. of selective serotonin reuptake inhibitors. Cell Mol. Neurobiol. 19, 443-466. Encinas, J.M., Vaahtokari, A., Enikolopov, G., 2006. Fluoxetine targets early progenitor cells in the adult Dijkhuizen, R.M., Nicolay, K., 2003. Magnetic resonance brain. Proc.Natl.Acad.Sci.U.S.A 103, 8233-8238. imaging in experimental models of brain disorders. J Cereb.Blood Flow Metab 23, 1383-1402. Endicott, J., Spitzer, R.L., Fleiss, J.L., Cohen, J., 1976. The global assessment scale. A procedure for measuring Downey, D., Juhasz, G., McKie, S., Davies, K.E., Thomas, overall severity of psychiatric disturbance. Arch.Gen. E., Chase, D., Elliott, R., Deakin, J.W., Anderson, Psychiatry 33, 766-771. I., Williams, S., 2010. Short-long functional polymorphism of serotonin transporter gene Engelbregt, M.J., Houdijk, M.E., Popp-Snijders, C., modulates the acute citalopram challenge phMRI Delemarre-van de Waal HA, 2000. The effects of response. Poster no. 2299 at the ISMRM annual intra-uterine growth retardation and postnatal meeting, 18 ed. undernutrition on onset of puberty in male and female rats. Pediatr Res. 48, 803-807. Drevets, W.C., Price, J.L., Furey, M.L., 2008. Brain structural and functional abnormalities in mood Epstein, J.N., Casey, B.J., Tonev, S.T., Davidson, M.C., disorders: implications for neurocircuitry models of Reiss, A.L., Garrett, A., Hinshaw, S.P., Greenhill, L.L., depression. Brain Struct.Funct. 213, 93-118. Glover, G., Shafritz, K.M., Vitolo, A., Kotler, L.A.,

240 References

Jarrett, M.A., Spicer, J., 2007. ADHD- and medication- Fuchs, E., Czeh, B., Kole, M.H., Michaelis, T., Lucassen, related brain activation effects in concordantly P.J., 2004. Alterations of neuroplasticity in affected parent-child dyads with ADHD. J.Child depression: the hippocampus and beyond. Eur. Psychol.Psychiatry 48, 899-913. Neuropsychopharmacol. 14 Suppl 5, S481-S490.

Farde, L., Halldin, C., Muller, L., Suhara, T., Karlsson, P., Fusar-Poli, P., Placentino, A., Carletti, F., Landi, P., Hall, H., 1994. PET study of [11C]beta-CIT binding to Allen, P., Surguladze, S., Benedetti, F., Abbamonte, monoamine transporters in the monkey and human M., Gasparotti, R., Barale, F., Perez, J., McGuire, P., brain. Synapse 16, 93-103. Politi, P., 2009. Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 Faure, C., Mnie-Filali, O., Haddjeri, N., 2006. Long- functional magnetic resonance imaging studies. term adaptive changes induced by serotonergic J.Psychiatry Neurosci. 34, 418-432. antidepressant drugs. Expert.Rev.Neurother. 6, 235- 245. Garcia, A., Steiner, B., Kronenberg, G., Bick-Sander, A., Kempermann, G., 2004. Age-dependent expression Fernandez, S.P., Gaspar, P., 2012. Investigating anxiety of glucocorticoid- and mineralocorticoid receptors and depressive-like phenotypes in genetic mouse on neural precursor cell populations in the adult models of serotonin depletion. Neuropharmacology murine hippocampus. Aging Cell 3, 363-371. 62, 144-154. Gardier, A.M., Lepoul, E., Trouvin, J.H., Chanut, E., Ferrari, L., Turrini, G., Crestan, V., Bertani, S., Cristofori, Dessalles, M.C., Jacquot, C., 1994. Changes in P., Bifone, A., Gozzi, A., 2011. A robust experimental dopamine metabolism in rat forebrain regions protocol for pharmacological fMRI in rats and mice. after cessation of long-term fluoxetine treatment: J.Neurosci.Methods 204, 9-18. relationship with brain concentrations of fluoxetine Fike, J.R., Rola, R., Limoli, C.L., 2007. Radiation response and norfluoxetine. Life Sci. 54, L51-L56. of neural precursor cells. Neurosurg.Clin.N.Am. 18, Gaspar, P., Cases, O., Maroteaux, L., 2003. The 115-27, x. developmental role of serotonin: news from mouse Findling, R.L., McNamara, N.K., Stansbrey, R.J., Feeny, molecular genetics. Nat.Rev Neurosci 4, 1002-1012. N.C., Young, C.M., Peric, F.V., Youngstrom, E.A., Geldof, M., Freijer, J.I., van Beijsterveldt, L., 2006. The relevance of pharmacokinetic studies in Langlois, X., Danhof, M., 2008. Pharmacokinetic- designing efficacy trials in juvenile major depression. pharmacodynamic modelling of fluvoxamine J.Child Adolesc.Psychopharmacol. 16, 131-145. 5-HT transporter occupancy in rat frontal cortex. Fliers, E.A., Vasquez, A.A., Poelmans, G., Rommelse, N., Br.J.Pharmacol. 154, 1369-1378. Altink, M., Buschgens, C., Asherson, P., Banaschewski, Gevers, S., van Osch, M.J., Bokkers, R.P., Kies, D.A., T., Ebstein, R., Gill, M., Miranda, A., Mulas, F., Oades, Teeuwisse, W.M., Majoie, C.B., Hendrikse, J., R.D., Roeyers, H., Rothenberger, A., Sergeant, J., Nederveen, A.J., 2011. Intra- and multicenter Sonuga-Barke, E., Steinhausen, H.C., Faraone, S.V., reproducibility of pulsed, continuous and pseudo- Buitelaar, J.K., Franke, B., 2012. Genome-wide continuous arterial spin labeling methods for association study of motor coordination problems in measuring cerebral perfusion. J.Cereb.Blood Flow ADHD identifies genes for brain and muscle function. Metab 31, 1706-1715. World J.Biol.Psychiatry 13, 211-222. Geyer, M.A., 1996. Serotonergic functions in arousal Fox, M.D., Raichle, M.E., 2007. Spontaneous fluctuations and motor activity. Behav.Brain Res. 73, 31-35. in brain activity observed with functional magnetic resonance imaging. Nat.Rev.Neurosci. 8, 700-711. Gibbons, R.D., Hur, K., Bhaumik, D.K., Mann, J.J., 2006. The Relationship Between Antidepressant Fox, M.D., Snyder, A.Z., Vincent, J.L., Corbetta, M., Van Prescription Rates and Rate of Early Adolescent Essen, D.C., Raichle, M.E., 2005. The human brain is Suicide. American Journal of Psychiatry 163, 1898- intrinsically organized into dynamic, anticorrelated 1904. functional networks. Proc.Natl.Acad.Sci.U.S.A 102, 9673-9678. & 241 Appendix

Giedd, J.N., 2008. The teen brain: insights from Grund, T., Lehmann, K., Bock, N., Rothenberger, neuroimaging. J Adolesc Health 42, 335-343. A., Teuchert-Noodt, G., 2006. Influence of methylphenidate on brain development--an update Golay, X., Hendrikse, J., Lim, T.C., 2004. Perfusion of recent animal experiments. Behav.Brain Funct. 2, imaging using arterial spin labeling. Top.Magn 2. Reson.Imaging 15, 10-27. Gsell, W., De Sadeleer, C., Marchalant, Y., MacKenzie, Gould, R.W., Gage, H.D., Banks, M.L., Blaylock, B.L., E.T., Schumann, P., Dauphin, F., 2000. The use Czoty, P.W., Nader, M.A., 2011. Differential effects of of cerebral blood flow as an index of neuronal cocaine and MDMA self-administration on cortical activity in functional neuroimaging: experimental serotonin transporter availability in monkeys. and pathophysiological considerations. Journal of Neuropharmacology 61, 245-251. Chemical Neuroanatomy 20, 215-224. Gozzi, A., Crestan, V., Turrini, G., Clemens, M., Bifone, A., Guelfi, J.D., Strub, N., Loft, H., 2000. Efficacy of 2010. Antagonism at serotonin 5-HT(2A) receptors intravenous citalopram compared with oral modulates functional activity of frontohippocampal citalopram for severe depression. Safety and efficacy circuit. Psychopharmacology (Berl) 209, 37-50. data from a double-blind, double-dummy trial. J Gozzi, A., Large, C.H., Schwarz, A., Bertani, S., Crestan, V., Affect.Disord. 58, 201-209. Bifone, A., 2008. Differential effects of antipsychotic Guy, M., 1976. ECDEU assessment manual for and glutamatergic agents on the phMRI response to psychopharmacology. National Institute of Mental phencyclidine. Neuropsychopharmacology 33, 1690- Health, Rockville MD. 1703. Hamilton, M., 1969. Diagnosis and rating of anxiety. Gray, J.D., Punsoni, M., Tabori, N.E., Melton, J.T., Br.J.Psychiatry Special Pub. 3, 76-79. Fanslow, V., Ward, M.J., Zupan, B., Menzer, D., Rice, J., Drake, C.T., Romeo, R.D., Brake, W.G., Torres- Hammad, T.A., Laughren, T., Racoosin, J., 2006. Reveron, A., Milner, T.A., 2007. Methylphenidate Suicidality in Pediatric Patients Treated With administration to juvenile rats alters brain areas Antidepressant Drugs. Archives of General Psychiatry involved in cognition, motivated behaviors, appetite, 63, 332-339. and stress. J.Neurosci. 27, 7196-7207. Hansen, F., de Oliveira, D.L., Amaral, F.U., Guedes, F.S., Greicius, M.D., Flores, B.H., Menon, V., Glover, G.H., Schneider, T.J., Tumelero, A.C., Hansel, G., Schmidt, Solvason, H.B., Kenna, H., Reiss, A.L., Schatzberg, A.F., K.H., Giacomini, A.C., Torres, F.V., 2011. Effects of 2007. Resting-state functional connectivity in major chronic administration of tryptophan with or without depression: abnormally increased contributions concomitant fluoxetine in depression-related and from subgenual cingulate cortex and thalamus. Biol. anxiety-like behaviors on adult rat. Neurosci.Lett. Psychiatry 62, 429-437. 499, 59-63.

Griebel, G., Cohen, C., Perrault, G., Sanger, D.J., 1999. Hanson, N.D., Nemeroff, C.B., Owens, M.J., 2011a. Behavioral effects of acute and chronic fluoxetine in Lithium, but not fluoxetine or the corticotropin- Wistar-Kyoto rats. Physiol Behav. 67, 315-320. releasing factor receptor 1 receptor antagonist R121919, increases cell proliferation in the adult Grimm, S., Boesiger, P., Beck, J., Schuepbach, D., dentate gyrus. J.Pharmacol.Exp.Ther. 337, 180-186. Bermpohl, F., Walter, M., Ernst, J., Hell, D., Boeker, H., Northoff, G., 2009. Altered negative BOLD Hanson, N.D., Owens, M.J., Boss-Williams, K.A., Weiss, responses in the default-mode network during J.M., Nemeroff, C.B., 2011b. Several stressors emotion processing in depressed subjects. fail to reduce adult hippocampal neurogenesis. Neuropsychopharmacology 34, 932-943. Psychoneuroendocrinology 36, 1520-1529.

Hariri, A.R., Tessitore, A., Mattay, V.S., Fera, F., Weinberger, D.R., 2002. The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage. 17, 317-323.

242 References

Harmer, C.J., O’Sullivan, U., Favaron, E., Massey- Hetrick, S., Merry, S., McKenzie, J., Sindahl, P., Proctor, Chase, R., Ayres, R., Reinecke, A., Goodwin, G.M., M., 2007. Selective serotonin reuptake inhibitors Cowen, P.J., 2009. Effect of acute antidepressant (SSRIs) for depressive disorders in children and administration on negative affective bias in adolescents. Cochrane.Database.Syst.Rev., depressed patients. Am.J.Psychiatry 166, 1178-1184. CD004851.

Harmer, C.J., Mackay, C.E., Reid, C.B., Cowen, P.J., Hiemke, Ch., Härtter, S., 2000. Pharmacokinetics Goodwin, G.M., 2006. Antidepressant Drug of selective serotonin reuptake inhibitors. Treatment Modifies the Neural Processing of Pharmacology & Therapeutics 85, 11-28. Nonconscious Threat Cues. Biological Psychiatry 59, Hindmarch, I., 1995. The behavioural toxicity of the 816-820. selective serotonin reuptake inhibitors. Int.Clin. Hasin, D.S., Goodwin, R.D., Stinson, F.S., Grant, B.F., Psychopharmacol. 9 Suppl 4, 13-17. 2005. Epidemiology of major depressive disorder: Hodes, G.E., Yang, L., Van Kooy, .J., Santollo, J., Shors, results from the National Epidemiologic Survey T.J., 2009. Prozac during puberty: distinctive effects on Alcoholism and Related Conditions. Arch.Gen. on neurogenesis as a function of age and sex. Psychiatry 62, 1097-1106. Neuroscience 163, 609-617. Hatzidimitriou, G., McCann, U.D., Ricaurte, G.A., Homberg, J.R., Olivier, J.D., Blom, T., Arentsen, T., van 1999. Altered serotonin innervation patterns Brunschot, C., Schipper, P., Korte-Bouws, G., van in the forebrain of monkeys treated with Luijtelaar, G., Reneman, L., 2011. Fluoxetine exerts (+/-)3,4-methylenedioxymethamphetamine seven age-dependent effects on behavior and amygdala years previously: factors influencing abnormal neuroplasticity in the rat. PLoS.ONE. 6, e16646. recovery. J.Neurosci. 19, 5096-5107. Homberg, J.R., Schubert, D., Gaspar, P., 2010. New Havel, P., Braun, B., Rau, S., Tonn, J.C., Fesl, G., perspectives on the neurodevelopmental effects of Bruckmann, H., Ilmberger, J., 2006. Reproducibility SSRIs. Trends Pharmacol.Sci. 31, 60-65. of activation in four motor paradigms. An fMRI study. J.Neurol. 253, 471-476. Houston, G.C., Papadakis, N.G., Carpenter, T.A., Hall, L.D., Mukherjee, B., James, M.F., Huang, C.L., Hazell, P., O’Connell, D., Heathcote, D., Henry, D., 2001. Mapping of brain activation in response to 2000. Tricyclic drugs for depression in children pharmacological agents using fMRI in the rat. Magn and adolescents. Cochrane.Database.Syst.Rev., Reson.Imaging 19, 905-919. CD002317. Hu, X.Z., Rush, A.J., Charney, D., Wilson, A.F., Sorant, Heils, A., Mossner, R., Lesch, K.P., 1997. The human A.J., Papanicolaou, G.J., Fava, M., Trivedi, M.H., serotonin transporter gene polymorphism--basic Wisniewski, S.R., Laje, G., Paddock, S., McMahon, research and clinical implications. J.Neural Transm. F.J., Manji, H., Lipsky, R.H., 2007. Association 104, 1005-1014. between a functional serotonin transporter Heils, A., Teufel, A., Petri, S., Stober, G., Riederer, P., promoter polymorphism and citalopram treatment Bengel, D., Lesch, K.P., 1996. Allelic variation of in adult outpatients with major depression. Arch. human serotonin transporter gene expression. Gen.Psychiatry 64, 783-792. J.Neurochem. 66, 2621-2624. Huang, G.J., Herbert, J., 2006. Stimulation of Heine, V.M., Maslam, S., Joels, M., Lucassen, P.J., 2004. neurogenesis in the hippocampus of the adult Prominent decline of newborn cell proliferation, rat by fluoxetine requires rhythmic change in differentiation, and apoptosis in the aging dentate corticosterone. Biol.Psychiatry 59, 619-624. gyrus, in absence of an age-related hypothalamus- Huang, Y.S., Tsai, M.H., Guilleminault, C., 2011. pituitary-adrenal axis activation. Neurobiol.Aging 25, Pharmacological treatment of ADHD and the short 361-375. and long term effects on sleep. Curr.Pharm.Des 17, 1450-1458. & 243 Appendix

Hwang, L.C., Chang, C.J., Liu, H.H., Kao, H.C., Lee, S.Y., Jureidini, J.N., Doecke, C.J., Mansfield, P.R., Haby, M.M., Jan, M.L., Chen, C.C., 2007. Imaging the availability Menkes, D.B., Tonkin, A.L., 2004. Efficacy and safety of serotonin transporter in rat brain with 123I-ADAM of antidepressants for children and adolescents. BMJ and small-animal SPECT. Nucl.Med.Commun. 28, 328, 879-883. 615-621. Kaneko, T., Akiyama, H., Nagatsu, I., Mizuno, N., Imeraj, L., Sonuga-Barke, E., Antrop, I., Roeyers, H., 1990. Immunohistochemical demonstration of Wiersema, R., Bal, S., Deboutte, D., 2012. Altered glutaminase in catecholaminergic and serotoninergic circadian profiles in attention-deficit/hyperactivity neurons of rat brain. Brain Res. 507, 151-154. disorder: an integrative review and theoretical Kanfer, J., Parenty, M., Goujet-Zalc, C., Monge, M., framework for future studies. Neurosci.Biobehav. Bernier, L., Campagnoni, A.T., Dautigny, A., Zalc, Rev. 36, 1897-1919. B., 1989. Developmental expression of myelin Iñiguez, S.D., Warren, B.L., Bolanos-Guzman, C.A., proteolipid, basic protein, and 2’,3’-cyclic nucleotide 2010. Short- and long-term functional consequences 3’-phosphodiesterase transcripts in different rat of fluoxetine exposure during adolescence in male brain regions. J.Mol.Neurosci. 1, 39-46. rats. Biol.Psychiatry 67, 1057-1066. Kapornai, K., Vetro, A., 2008. Depression in children. Invernizzi, R., Bramante, M., Samanin, R., 1996. Role Curr.Opin.Psychiatry 21, 1-7. of 5-HT1A receptors in the effects of acute chronic Karanges, E., Li, K.M., Motbey, C., Callaghan, P.D., fluoxetine on extracellular serotonin in the frontal Katsifis, A., McGregor, I.S., 2011. Differential cortex. Pharmacol.Biochem.Behav. 54, 143-147. behavioural and neurochemical outcomes from Jacobs, B.L., Azmitia, E.C., 1992. Structure and function chronic paroxetine treatment in adolescent and adult of the brain serotonin system. Physiological Reviews rats: a model of adverse antidepressant effects in 72, 165-229. human adolescents? Int.J.Neuropsychopharmacol. 14, 491-504. Jacobs, B.L., Fornal, C.A., 1999. Activity of serotonergic neurons in behaving animals. Kearns, G.L., Abdel-Rahman, S.M., Alander, S.W., Neuropsychopharmacology 21, 9S-15S. Blowey, D.L., Leeder, J.S., Kauffman, R.E., 2003. Developmental pharmacology--drug disposition, Jenkins, B.G., Sanchez-Pernaute, R., Brownell, A.L., action, and therapy in infants and children. Chen, Y.C., Isacson, O., 2004. Mapping dopamine N.Engl.J.Med. 349, 1157-1167. function in primates using pharmacologic magnetic resonance imaging. J.Neurosci. 24, 9553-9560. Kerkhof, G.A., Geuke, M.E., Brouwer, A., Rijsman, R.M., Schimsheimer, R.J., Van Kasteel, V., 2013. Jha, S., Rajendran, R., Fernandes, K.A., Vaidya, V.A., Holland Sleep Disorders Questionnaire: a new sleep 2008. 5-HT2A/2C receptor blockade regulates disorders questionnaire based on the International progenitor cell proliferation in the adult rat Classification of Sleep Disorders-2. J.Sleep Res. 22, hippocampus. Neurosci.Lett. 441, 210-214. 104-107. Joëls, M., Karst, H., Krugers, H.J., Lucassen, P.J., Kessler, R.C., Avenevoli, S., Ries, M.K., 2001. 2007. Chronic stress: implications for neuronal Mood disorders in children and adolescents: an morphology, function and neurogenesis. Front epidemiologic perspective. Biol.Psychiatry 49, 1002- Neuroendocrinol. 28, 72-96. 1014. Johnson, K.A., Robertson, I.H., Kelly, S.P., Silk, T.J., Barry, Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, E., Daibhis, A., Watchorn, A., Keavey, M., Fitzgerald, K.R., Walters, E.E., 2005. Prevalence, severity, and M., Gallagher, L., Gill, M., Bellgrove, M.A., 2007. comorbidity of 12-month DSM-IV disorders in the Dissociation in performance of children with ADHD National Comorbidity Survey Replication. Arch.Gen. and high-functioning autism on a task of sustained Psychiatry 62, 617-627. attention. Neuropsychologia 45, 2234-2245.

244 References

Kimble, C.J., Johnson, D.M., Winter, B.A., Whitlock, S.V., Kodama, M., Fujioka, T., Duman, R.S., 2004. Chronic Kressin, K.R., Horne, A.E., Robinson, J.C., Bledsoe, olanzapine or fluoxetine administration increases J.M., Tye, S.J., Chang, S.Y., Agnesi, F., Griessenauer, cell proliferation in hippocampus and prefrontal C.J., Covey, D., Shon, Y.M., Bennet, K.E., Garris, cortex of adult rat. Biol.Psychiatry 56, 570-580. P.A., Lee, K.H., 2009. Wireless Instantaneous Kooij, J.J.S., 2012. Adult ADHD: Diagnostic assessment Neurotransmitter Concentration Sensing System and treatment, 3rd ed. Springer. (WINCS) for intraoperative neurochemical monitoring. Conf.Proc.IEEE Eng Med.Biol.Soc. 2009, Korosi, A., Naninck, E.F., Oomen, C.A., Schouten, M., 4856-4859. Krugers, H., Fitzsimons, C., Lucassen, P.J., 2012. Early-life stress mediated modulation of adult Kirchheiner, J., Brosen, K., Dahl, M.L., Gram, L.F., Kasper, neurogenesis and behavior. Behav.Brain Res. 227, S., Roots, I., Sjoqvist, F., Spina, E., Brockmoller, J., 400-409. 2001. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step Kronenberg, S., Apter, A., Brent, D., Schirman, S., towards subpopulation-specific dosages. Acta Melhem, N., Pick, N., Gothelf, D., Carmel, M., Psychiatr.Scand. 104, 173-192. Frisch, A., Weizman, A., 2007. Serotonin transporter polymorphism (5-HTTLPR) and citalopram Klempin, F., Babu, H., De Pietri, T.D., Alarcon, E., Fabel, effectiveness and side effects in children with K., Kempermann, G., 2010. Oppositional effects depression and/or anxiety disorders. J.Child Adolesc. of serotonin receptors 5-HT1a, 2, and 2c in the Psychopharmacol. 17, 741-750. regulation of adult hippocampal neurogenesis. Front Mol.Neurosci. 3. Kunisato, Y., Okamoto, Y., Okada, G., Aoyama, S., Demoto, Y., Munakata, A., Nomura, M., Onoda, K., Klomp, A., Caan, M.W., Denys, D., Nederveen, A.J., Yamawaki, S., 2011. Modulation of default-mode Reneman, L., 2012a. Feasibility of ASL-based phMRI network activity by acute tryptophan depletion with a single dose of oral citalopram for repeated is associated with mood change: a resting state assessment of serotonin function. Neuroimage. 63, functional magnetic resonance imaging study. 1695-1700. Neurosci.Res. 69, 129-134. Klomp, A., Tremoleda, J.L., Wylezinska, M., Nederveen, Kuntsi, J., Oosterlaan, J., Stevenson, J., 2001. A.J., Feenstra, M., Gsell, W., Reneman, L., 2012b. Psychological mechanisms in hyperactivity: I. Lasting effects of chronic fluoxetine treatment on the Response inhibition deficit, working memory late developing rat brain: age-dependent changes in impairment, delay aversion, or something else? the serotonergic neurotransmitter system assessed J.Child Psychol.Psychiatry 42, 199-210. by pharmacological MRI. Neuroimage. 59, 218-226. Lancet Editorial Note, 2006. Clinical trials in children, Knol, R.J., de Bruin, K., de Jong, J., van Eck-Smit, B.L., for children. Lancet 367, 1953. Booij, J., 2008. In vitro and ex vivo storage phosphor imaging of short-living radioisotopes. J Neurosci LaRoche, R.B., Morgan, R.E., 2007. Adolescent Methods 168, 341-357. fluoxetine exposure produces enduring, sex-specific alterations of visual discrimination and attention in Knoth, R., Singec, I., Ditter, M., Pantazis, G., Capetian, rats. Neurotoxicology and Teratology 29, 96-107. P., Meyer, R.P., Horvat, V., Volk, B., Kempermann, G., 2010. Murine features of neurogenesis in the Laruelle, M., Baldwin, R.M., Malison, R.T., Zea-Ponce, human hippocampus across the lifespan from 0 to Y., Zoghbi, S.S., al-Tikriti, M.S., Sybirska, E.H., 100 years. PLoS.ONE. 5, e8809. Zimmermann, R.C., Wisniewski, G., Neumeyer, J.L., ., 1993. SPECT imaging of dopamine and serotonin Kobayashi, K., Ikeda, Y., Sakai, A., Yamasaki, N., Haneda, transporters with [123I]beta-CIT: pharmacological E., Miyakawa, T., Suzuki, H., 2010. Reversal of characterization of brain uptake in nonhuman hippocampal neuronal maturation by serotonergic primates. Synapse 13, 295-309. antidepressants. Proc.Natl.Acad.Sci.U.S.A 107, 8434- 8439. & 245 Appendix

Lauder, J.M., 1990. Ontogeny of the serotonergic Li, X.M., Perry, K.W., Wong, D.T., 1999. Difference in system in the rat: serotonin as a developmental the in vivo influence of serotonin1A autoreceptors signal. Ann.N.Y.Acad.Sci. 600, 297-313. on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine. Lauder, J.M., Krebs, H., 1978. Serotonin as a Chin J.Physiol 42, 53-59. differentiation signal in early neurogenesis. Dev. Neurosci. 1, 15-30. Lifschytz, T., Shalom, G., Lerer, B., Newman, M.E., 2006. Sex-dependent effects of fluoxetine and Lauder, J.M., Tamir, H., Sadler, T.W., 1988. Serotonin triiodothyronine in the forced swim test in rats. Eur. and morphogenesis. I. Sites of serotonin uptake Neuropsychopharmacol. 16, 115-121. and -binding protein immunoreactivity in the midgestation mouse embryo. Development 102, Logothetis, N.K., Pauls, J., Augath, M., Trinath, 709-720. T., Oeltermann, A., 2001. Neurophysiological investigation of the basis of the fMRI signal. Nature Lauder, J.M., Wallace, J.A., Wilkie, M.B., DiNome, A., 412, 150-157. Krebs, H., 1983. Roles for serotonin in neurogenesis. Monogr Neural Sci. 9, 3-10. Logothetis, N.K., Wandell, B.A., 2004. Interpreting the BOLD signal. Annu.Rev.Physiol 66, 735-769. Laurent, A., Goaillard, J.M., Cases, O., Lebrand, C., Gaspar, P., Ropert, N., 2002. Activity-dependent Lopez-Duran, N.L., Kovacs, M., George, C.J., 2009. presynaptic effect of serotonin 1B receptors on the Hypothalamic-pituitary-adrenal axis dysregulation somatosensory thalamocortical transmission in in depressed children and adolescents: a meta- neonatal mice. Journal of Neuroscience 22, 886-900. analysis. Psychoneuroendocrinology 34, 1272-1283.

Leonard, B.E., 2007. Psychopathology of depression. Lotrich, F.E., Pollock, B.G., Ferrell, R.E., 2001. Drugs Today (Barc.) 43, 705-716. Polymorphism of the serotonin transporter: implications for the use of selective serotonin Lesch, K.P., Aulakh, C.S., Wolozin, B.L., Tolliver, T.J., Hill, reuptake inhibitors. Am.J.Pharmacogenomics. 1, J.L., Murphy, D.L., 1993. Regional brain expression 153-164. of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Brain Res.Mol. Loubinoux, I., Boulanouar, K., Ranjeva, J.P., Carel, Brain Res. 17, 31-35. C., Berry, I., Rascol, O., Celsis, P., Chollet, F., 1999. Cerebral functional magnetic resonance Lesch, K.P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, imaging activation modulated by a single dose of B.D., Petri, S., Benjamin, J., Muller, C.R., Hamer, the monoamine neurotransmission enhancers D.H., Murphy, D.L., 1996. Association of anxiety- fluoxetine and fenozolone during hand sensorimotor related traits with a polymorphism in the serotonin tasks. J Cereb.Blood Flow Metab 19, 1365-1375. transporter gene regulatory region. Science 274, 1527-1531. Loubinoux, I., Pariente, J., Boulanouar, K., Carel, C., Manelfe, C., Rascol, O., Celsis, P., Chollet, F., 2002. Leslie, R.A., James, M.F., 2000. Pharmacological A single dose of the serotonin neurotransmission magnetic resonance imaging: a new application for agonist paroxetine enhances motor output: double- functional MRI. Trends Pharmacol.Sci. 21, 314-318. blind, placebo-controlled, fMRI study in healthy Lew, R., Sabol, K.E., Chou, C., Vosmer, subjects. NeuroImage 15, 26-36. G.L., Richards, J., Seiden, L.S., 1996. Lucassen, P.J., Meerlo, P., Naylor, A.S., van Dam, A.M., Methylenedioxymethamphetamine-induced Dayer, A.G., Fuchs, E., Oomen, C.A., Czeh, B., 2010a. serotonin deficits are followed by partial recovery Regulation of adult neurogenesis by stress, sleep over a 52-week period. Part II: Radioligand binding disruption, exercise and inflammation: Implications and autoradiography studies. J.Pharmacol.Exp.Ther. for depression and antidepressant action. Eur. 276, 855-865. Neuropsychopharmacol. 20, 1-17.

246 References

Lucassen, P.J., Stumpel, M.W., Wang, Q., Aronica, Mareckova, K., Perrin, J.S., Nawaz, K., I, Lawrence, C., E., 2010b. Decreased numbers of progenitor Dickie, E., McQuiggan, D.A., Paus, T., 2012. Hormonal cells but no response to antidepressant drugs in contraceptives, menstrual cycle and brain response the hippocampus of elderly depressed patients. to faces. Soc.Cogn Affect.Neurosci. [ePub ahead of Neuropharmacology 58, 940-949. print].

Luo, F., Schmidt, K.F., Fox, G.B., Ferris, C.F., 2009. Marlatt, M.W., Lucassen, P.J., van Praag, H., 2010. Differential responses in CBF and CBV to cocaine as Comparison of neurogenic effects of fluoxetine, measured by fMRI: implications for pharmacological duloxetine and running in mice. Brain Res. 1341, 93- MRI signals derived oxygen metabolism assessment. 99. J.Psychiatr.Res. 43, 1018-1024. Marlatt, M.W., Philippens, I., Manders, E., Czeh, B., Lyles, J., Cadet, J.L., 2003. Joels, M., Krugers, H., Lucassen, P.J., 2011. Distinct Methylenedioxymethamphetamine (MDMA, structural plasticity in the hippocampus and Ecstasy) neurotoxicity: cellular and molecular amygdala of the middle-aged common marmoset mechanisms. Brain Res.Brain Res.Rev. 42, 155-168. (Callithrix jacchus). Exp.Neurol. 230, 291-301.

MacGillivray, L., Lagrou, L.M., Reynolds, K.B., Rosebush, Marlatt, M.W., Potter, M.C., Lucassen, P.J., van Praag, P.I., Mazurek, M.F., 2010. Role of serotonin H., 2012. Running throughout middle-age improves transporter inhibition in the regulation of tryptophan memory function, hippocampal neurogenesis, and hydroxylase in brainstem raphe nuclei: time course BDNF levels in female C57BL/6J mice. Dev.Neurobiol. and regional specificity. Neuroscience 171, 407-420. 72, 943-952.

Maciag, D., Simpson, K.L., Coppinger, D., Lu, Y., Wang, Martin, C., Sibson, N.R., 2008. Pharmacological MRI Y., Lin, R.C., Paul, I.A., 2006. Neonatal antidepressant in animal models: A useful tool for 5-HT research? exposure has lasting effects on behavior and Neuropharmacology 55, 1038-1047. serotonin circuitry. Neuropsychopharmacology 31, Martin, G.R., 1994. Vascular receptors for 47-57. 5-hydroxytryptamine: distribution, function and Madsen, T.M., Yeh, D.D., Valentine, G.W., Duman, classification. Pharmacol.Ther. 62, 283-324. R.S., 2005. Electroconvulsive seizure treatment Mason, S.S., Baker, K.B., Davis, K.W., Pogorelov, V.M., increases cell proliferation in rat frontal cortex. Malbari, M.M., Ritter, R., Wray, S.P., Gerhardt, B., Neuropsychopharmacology 30, 27-34. Lanthorn, T.H., Savelieva, K.V., 2009. Differential Malberg, J.E., Duman, R.S., 2003. Cell proliferation in sensitivity to SSRI and tricyclic antidepressants in adult hippocampus is decreased by inescapable juvenile and adult mice of three strains. European stress: reversal by fluoxetine treatment. Journal of Pharmacology 602, 306-315. Neuropsychopharmacology 28, 1562-1571. Mathew, R.J., Wilson, W.H., 1991. Substance abuse and Malberg, J.E., Eisch, A.J., Nestler, E.J., Duman, R.S., cerebral blood flow. Am.J.Psychiatry 148, 292-305. 2000. Chronic antidepressant treatment increases McCormick, C.M., Mathews, I.Z., 2007. HPA function in neurogenesis in adult rat hippocampus. Journal of adolescence: role of sex hormones in its regulation Neuroscience 20, 9104-9110. and the enduring consequences of exposure to March, J.S., Vitiello, B., 2009. Clinical messages from stressors. Pharmacol.Biochem.Behav. 86, 220-233. the Treatment for Adolescents With Depression McGraw, K.O., Wong, S.P., 1996. Forming inferences Study (TADS). Am.J.Psychiatry 166, 1118-1123. about some intraclass correlation coefficients. 1 ed, Marcussen, A.B., Flagstad, P., Kristjansen, P.E., pp. 30-46. Johansen, F.F., Englund, U., 2008. Increase in McKie, S., Del-Ben, C., Elliott, R., Williams, S., del Vai, neurogenesis and behavioural benefit after chronic N., Anderson, I., Deakin, J.F., 2005. Neuronal effects fluoxetine treatment in Wistar rats. Acta Neurol. of acute citalopram detected by pharmacoMRI. Scand. 117, 94-100. Psychopharmacology (Berl) 180, 680-686. & 247 Appendix

Meltzer, H.Y., 1990. Role of serotonin in depression. monoamine transporters in different regions of the Ann.N.Y.Acad.Sci. 600, 486-499. rat brain from early juvenile life to late adulthood. Brain Res.Dev.Brain Res. 119, 251-257. Mendoza, L., Hajduch, M., Kekulova, H., Svobodova, X., Mihal, V., Svoboda, M., 2005. Bioequivalence of two Mori, S., Zhang, J., 2006. Principles of diffusion tensor brands of citalopram 40 mg tablets after single oral imaging and its applications to basic neuroscience administration to healthy volunteers. Biomed.Pap. research. Neuron 51, 527-539. Med.Fac.Univ Palacky.Olomouc.Czech.Repub. 149, Morrison, J.L., Riggs, K.W., Rurak, D.W., 2005. Fluoxetine 169-172. during pregnancy: impact on fetal development. Merikangas, K.R., He, J.P., Burstein, M., Swanson, Reprod.Fertil.Dev. 17, 641-650. S.A., Avenevoli, S., Cui, L., Benjet, C., Georgiades, Mourilhe, P., Stokes, P.E., 1998. Risks and benefits K., Swendsen, J., 2010. Lifetime prevalence of of selective serotonin reuptake inhibitors in the mental disorders in U.S. adolescents: results from treatment of depression. Drug Saf 18, 57-82. the National Comorbidity Survey Replication-- Adolescent Supplement (NCS-A). J.Am.Acad.Child Moutsimilli, L., Farley, S., Dumas, S., El Mestikawy,.S., Adolesc.Psychiatry 49, 980-989. Giros, B., Tzavara, E.T., 2005. Selective cortical VGLUT1 increase as a marker for antidepressant Meyer, J.H., 2007. Imaging the serotonin transporter activity. Neuropharmacology 49, 890-900. during major depressive disorder and antidepressant treatment. J.Psychiatry Neurosci. 32, 86-102. Murphy, S.E., Norbury, R., O’Sullivan, U., Cowen, P.J., Harmer, C.J., 2009. Effect of a single dose of Meyer, J.S., Ali, S.F., 2002. Serotonergic neurotoxicity citalopram on amygdala response to emotional of MDMA (ecstasy) in the developing rat brain. faces. The British Journal of Psychiatry 194, 535-540. Ann.N.Y.Acad.Sci. 965, 373-380. Murray, M.L., Wong, I.C., de Vries, C.S., 2004. Treating Migliarini, S., Pacini, G., Pelosi, B., Lunardi, G., major depression in children and adolescents: Pasqualetti, M., 2012. Lack of brain serotonin affects research is needed into safer and more effective postnatal development and serotonergic neuronal drugs. BMJ 328, 524-525. circuitry formation. Mol.Psychiatry [ePub ahead of print]. Murrin, L.C., Sanders, J.D., Bylund, D.B., 2007. Comparison of the maturation of the adrenergic and Moeller, F.G., Hasan, K.M., Steinberg, J.L., Kramer, L.A., serotonergic neurotransmitter systems in the brain: Dougherty, D.M., Santos, R.M., Valdes, I., Swann, A.C., implications for differential drug effects on juveniles Barratt, E.S., Narayana, P.A., 2005. Reduced anterior and adults. Biochem.Pharmacol. 73, 1225-1236. corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability Nacher, J., McEwen, B.S., 2006. The role of N-methyl- in cocaine-dependent subjects: diffusion tensor D-asparate receptors in neurogenesis. Hippocampus imaging. Neuropsychopharmacology 30, 610-617. 16, 267-270.

Molina, B.S., Hinshaw, S.P., Swanson, J.M., Arnold, Navailles, S., Hof, P.R., Schmauss, C., 2008. L.E., Vitiello, B., Jensen, P.S., Epstein, J.N., Hoza, B., Antidepressant drug-induced stimulation of mouse Hechtman, L., Abikoff, H.B., Elliott, G.R., Greenhill, hippocampal neurogenesis is age-dependent and L.L., Newcorn, J.H., Wells, K.C., Wigal, T., Gibbons, altered by early life stress. J Comp Neurol. 509, 372- R.D., Hur, K., Houck, P.R., 2009. The MTA at 8 381. years: prospective follow-up of children treated for Nelissen, K., Smeets, K., Mulder, M., Hendriks, J.J., combined-type ADHD in a multisite study. J.Am. Ameloot, M., 2010. Selection of reference genes Acad.Child Adolesc.Psychiatry 48, 484-500. for gene expression studies in rat oligodendrocytes Moll, G.H., Mehnert, C., Wicker, M., Bock, N., using quantitative real time PCR. J.Neurosci.Methods Rothenberger, A., Ruther, E., Huether, G., 2000. Age- 187, 78-83. associated changes in the densities of presynaptic

248 References

Neumaier, J.F., Root, D.C., Hamblin, M.W., 1996. Chronic inhibitor antidepressants and maternal depression fluoxetine reduces serotonin transporter mRNA and using population-based linked health data. Archives 5-HT1B mRNA in a sequential manner in the rat of General Psychiatry 63, 898-906. dorsal raphe nucleus. Neuropsychopharmacology Oh, J.E., Zupan, B., Gross, S., Toth, M., 2009. Paradoxical 15, 515-522. anxiogenic response of juvenile mice to fluoxetine. Neumann, I.D., Wegener, G., Homberg, J.R., Cohen, Neuropsychopharmacology 34, 2197-2207. H., Slattery, D.A., Zohar, J., Olivier, J.D., Mathe, A.A., Olfson, M., Marcus, S.C., Shaffer, D., 2006. 2011. Animal models of depression and anxiety: Antidepressant drug therapy and suicide in severely What do they tell us about human condition? Prog. depressed children and adults: A case-control study. Neuropsychopharmacol.Biol.Psychiatry 35, 1357- Arch.Gen.Psychiatry 63, 865-872. 1375. Olivier, J.D., Blom, T., Arentsen, T., Homberg, J.R., 2011. Newman, M.E., Shalom, G., Ran, A., Gur, E., Van The age-dependent effects of selective serotonin de Kar, L.D., 2004. Chronic fluoxetine-induced reuptake inhibitors in humans and rodents: A review. desensitization of 5-HT1A and 5-HT1B autoreceptors: Prog. Neuropsychopharmacol.Biol.Psychiatry 35, regional differences and effects of WAY-100635. 1400-1408. Eur.J.Pharmacol. 486, 25-30. Oomen, C.A., Mayer, J.L., de Kloet, E.R., Joels, M., Nokia, M.S., Anderson, M.L., Shors, T.J., 2012. Lucassen, P.J., 2007. Brief treatment with the Chemotherapy disrupts learning, neurogenesis and glucocorticoid receptor antagonist mifepristone theta activity in the adult brain. Eur.J.Neurosci. 36, normalizes the reduction in neurogenesis after 3521-3530. chronic stress. Eur.J.Neurosci. 26, 3395-3401. Nollet, M., Gaillard, P., Tanti, A., Girault, V., Belzung, Oomen, C.A., Soeters, H., Audureau, N., Vermunt, L., C., Leman, S., 2012. Neurogenesis-independent van Hasselt, F.N., Manders, E.M., Joels, M., Krugers, antidepressant-like effects on behavior and H., Lucassen, P.J., 2011. Early maternal deprivation stress axis response of a dual orexin receptor affects dentate gyrus structure and emotional antagonist in a rodent model of depression. learning in adult female rats. Psychopharmacology Neuropsychopharmacology 37, 2210-2221. (Berl) 214, 249-260. Norcross, M., Poonam, M., Enoch, A., Karlsson, R.M., Oomen, C.A., Soeters, H., Audureau, N., Vermunt, Brigman, J., Cameron, H., Harvey-White, J., Holmes, L., van Hasselt, F.N., Manders, E.M., Joels, M., A., 2008. Effects of adolescent fluoxetine treatment Lucassen, P.J., Krugers, H., 2010. Severe early life on fear-, anxiety- or stress-related behaviors in stress hampers spatial learning and neurogenesis, C57BL/6J or BALB/cJ mice. Psychopharmacology but improves hippocampal synaptic plasticity and 200, 413-424. emotional learning under high-stress conditions in Norrholm, S.D., Ouimet, C.C., 2000. Chronic adulthood. J.Neurosci. 30, 6635-6645. fluoxetine administration to juvenile rats prevents Ossewaarde, L., Hermans, E.J., van Wingen, G.A., age-associated dendritic spine proliferation in Kooijman, S.C., Johansson, I.M., Backstrom, T., hippocampus. Brain Res. 883, 205-215. Fernandez, G., 2010. Neural mechanisms underlying O’Hearn, E., Battaglia, G., De Souza, E.B., Kuhar, M.J., changes in stress-sensitivity across the menstrual Molliver, M.E., 1988. Methylenedioxyamphetamine cycle. Psychoneuroendocrinology 35, 47-55. (MDA) and methylenedioxymethamphetamine Paizanis, E., Renoir, T., Lelievre, V., Saurini, F., (MDMA) cause selective ablation of serotonergic Melfort, M., Gabriel, C., Barden, N., Mocaer, E., axon terminals in forebrain: immunocytochemical Hamon, M., Lanfumey, L., 2010. Behavioural evidence for neurotoxicity. J.Neurosci. 8, 2788-2803. and neuroplastic effects of the new-generation Oberlander, T.F., Warburton, W., Misri, S., Aghajanian, antidepressant agomelatine compared to J., Hertzman, C., 2006. Neonatal outcomes after fluoxetine in glucocorticoid receptor-impaired mice. prenatal exposure to selective serotonin reuptake Int.J.Neuropsychopharmacol. 13, 759-774. & 249 Appendix

Park, D.H., Snyder, D.W., Joh, T.H., 1986. Postnatal restless legs syndrome in children with attention- developmental changes of tryptophan hydroxylase deficit hyperactivity disorder. Mov Disord. 14, 1000- activity in serotonergic cell bodies and terminals of 1007. rat brain. Brain Res. 378, 183-185. Pineyro, G., Blier, P., 1999. Autoregulation of serotonin Paterson, L.M., Kornum, B.R., Nutt, D.J., Pike, V.W., neurons: role in antidepressant drug action. Knudsen, G.M., 2013. 5-HT radioligands for human Pharmacol.Rev. 51, 533-591. brain imaging with PET and SPECT. Med.Res.Rev. 33, Pinnock, S.B., Blake, A.M., Platt, N.J., Herbert, J., 2010. 54-111. The roles of BDNF, pCREB and Wnt3a in the latent Paus, T., Zijdenbos, A., Worsley, K., Collins, D.L., period preceding activation of progenitor cell mitosis Blumenthal, J., Giedd, J.N., Rapoport, J.L., Evans, in the adult dentate gyrus by fluoxetine. PLoS.ONE. A.C., 1999. Structural maturation of neural pathways 5, e13652. in children and adolescents: in vivo study. Science Pinnock, S.B., Lazic, S.E., Wong, H.T., Wong, 283, 1908-1911. I.H., Herbert, J., 2009. Synergistic effects of Paxinos, G., Watson, C., 1986. The Rat Brain in dehydroepiandrosterone and fluoxetine on Stereotaxic Coordinates. Academic Press, Sydney. proliferation of progenitor cells in the dentate gyrus of the adult male rat. Neuroscience 158, 1644-1651. Pelham, W.E., Jr., Gnagy, E.M., Greenslade, K.E., Milich, R., 1992. Teacher ratings of DSM-III-R symptoms for Pirker, W., Asenbaum, S., Hauk, M., Kandlhofer, S., the disruptive behavior disorders. J.Am.Acad.Child Tauscher, J., Willeit, M., Neumeister, A., Praschak- Adolesc.Psychiatry 31, 210-218. Rieder, N., Angelberger, P., Brucke, T., 2000. Imaging serotonin and dopamine transporters with Pellow, S., Chopin, P., File, S.E., Briley, M., 1985. 123I-beta-CIT SPECT: binding kinetics and effects of Validation of open:closed arm entries in an elevated normal aging. J.Nucl.Med. 41, 36-44. plus-maze as a measure of anxiety in the rat. J.Neurosci.Methods 14, 149-167. Pittaluga, A., Raiteri, L., Longordo, F., Luccini, E., Barbiero, V.S., Racagni, G., Popoli, M., Raiteri, M., Perera, T.D., Dwork, A.J., Keegan, K.A., Thirumangalakudi, 2007. Antidepressant treatments and function of L., Lipira, C.M., Joyce, N., Lange, C., Higley, J.D., glutamate ionotropic receptors mediating amine Rosoklija, G., Hen, R., Sackeim, H.A., Coplan, J.D., release in hippocampus. Neuropharmacology 53, 2011. Necessity of hippocampal neurogenesis for 27-36. the therapeutic action of antidepressants in adult nonhuman primates. PLoS.ONE. 6, e17600. Porsolt, R.D., Le Pichon, M., Jalfre, M., 1977. Depression: a new animal model sensitive to antidepressant Perlman, S.B., Almeida, J.R., Kronhaus, D.M., Versace, treatments. Nature 266, 730-732. A., Labarbara, E.J., Klein, C.R., Phillips, M.L., 2012. Amygdala activity and prefrontal cortex-amygdala Poznanski, E.O., Cook, S.C., Carroll, B.J., 1979. A effective connectivity to emerging emotional faces depression rating scale for children. Pediatrics 64, distinguish remitted and depressed mood states in 442-450. bipolar disorder. Bipolar.Disord. 14, 162-174. Preece, M.A., Taylor, M.J., Raley, J., Blamire, A., Sharp, Perry, K.W., Fuller, R.W., 1992. Effect of fluoxetine T., Sibson, N.R., 2009. Evidence that increased 5-HT on serotonin and dopamine concentration in release evokes region-specific effects on blood- microdialysis fluid from rat striatum. Life Sci. 50, oxygenation level-dependent functional magnetic 1683-1690. resonance imaging responses in the rat brain. Neuroscience 159, 751-759. Picchietti, D.L., Underwood, D.J., Farris, W.A., Walters, A.S., Shah, M.M., Dahl, R.E., Trubnick, L.J., Bertocci, Raap, D.K., Garcia, F., Muma, N.A., Wolf, W.A., Battaglia, M.A., Wagner, M., Hening, W.A., 1999. Further G., Van de Kar, L.D., 1999. Sustained desensitization studies on periodic limb movement disorder and of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited

250 References

neuroendocrine responses to 8-hydroxy-2- 123-labeled beta-CIT and nor-beta-CIT binding to (Dipropylamino)Tetralin in the absence of changes in serotonin transporters in rat brain. Synapse 34, 77- Gi/o/z proteins. J Pharmacol Exp.Ther. 288, 561-567. 80.

Racagni, G., Popoli, M., 2008. Cellular and Reneman, L., Lavalaye, J., Schmand, B., de Wolff, molecular mechanisms in the long-term action of F.A., van den Brink, W., den Heeten, G.J., Booij, J., antidepressants. Dialogues.Clin.Neurosci. 10, 385- 2001b. Cortical serotonin transporter density and 400. verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or Rahimi, O., Claiborne, B.J., 2007. Morphological “ecstasy”): preliminary findings. Arch.Gen.Psychiatry development and maturation of granule neuron 58, 901-906. dendrites in the rat dentate gyrus. Prog.Brain Res. 163, 167-181. Reneman, L., Majoie, C.B., Habraken, J.B., den Heeten, G.J., 2001c. Effects of ecstasy (MDMA) on the brain Rainer, Q., Xia, L., Guilloux, J.P., Gabriel, C., Mocaer, in abstinent users: initial observations with diffusion E., Hen, R., Enhamre, E., Gardier, A.M., David, D.J., and perfusion MR imaging. Radiology 220, 611-617. 2012. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. Rey, J.M., Sawyer, M.G., 2003. Are psychostimulant Int.J.Neuropsychopharmacol. 15, 321-335. drugs being used appropriately to treat child and adolescent disorders? Br.J.Psychiatry 182, 284-286. Ramakers, C., Ruijter, J.M., Deprez, R.H., Moorman, A.F., 2003. Assumption-free analysis of quantitative Ricaurte, G.A., Yuan, J., McCann, U.D., 2000. real-time polymerase chain reaction (PCR) data. (+/-)3,4-Methylenedioxymethamphetamine Neurosci.Lett. 339, 62-66. (‘Ecstasy’)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42, 5-10. Ramsey, N.F., Tallent, K., van Gelderen, P., Frank, J.A., Moonen, C.T., Weinberger, D.R., 1996. Reproducibility Rijks, L.J., Booij, J., Doornbos, T., Boer, G.J., Ronken, E., de of human 3D fMRI brain maps acquired during a Bruin, K., Vermeulen, R.J., Janssen, A.G., Van Royen, motor task. Hum.Brain Mapp. 4, 113-121. E.A., 1996. In vitro and in vivo characterization of newly developed iodinated 1-[2-[bis(4-fluorophenyl) Rayen, I., van den Hove, D.L., Prickaerts, J., Steinbusch, methoxy]ethyl] piperazine derivatives in rats: limited H.W., Pawluski, J.L., 2011. Fluoxetine during value as dopamine transporter SPECT ligands. development reverses the effects of prenatal stress Synapse 23, 201-207. on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS.ONE. 6, e24003. Rind, H.B., Russo, A.F., Whittemore, S.R., 2000. Developmental regulation of tryptophan hydroxylase Reneman, L., Booij, J., de Bruin K., Reitsma, J.B., de messenger RNA expression and enzyme activity in Wolff, F.A., Gunning, W.B., den Heeten, G.J., van the raphe and its target fields. Neuroscience 101, den Brink, W., 2001a. Effects of dose, sex, and long- 665-677. term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358, Rogoz, Z., Golembiowska, K., 2010. Effect of metyrapone 1864-1869. on the fluoxetine-induced change in extracellular dopamine, serotonin and their metabolites in the rat Reneman, L., Booij, J., Habraken, J.B., de Bruin,.K., frontal cortex. Pharmacol.Rep. 62, 1015-1022. Hatzidimitriou, G., den Heeten, G.J., Ricaurte, G.A., 2002. Validity of [123I]beta-CIT SPECT in detecting Rosler, M., Retz, W., Thome, J., Schneider, M., Stieglitz, MDMA-induced serotonergic neurotoxicity. Synapse R.D., Falkai, P., 2006. Psychopathological rating scales 46, 199-205. for diagnostic use in adults with attention-deficit/ hyperactivity disorder (ADHD). Eur.Arch.Psychiatry Reneman, L., Booij, J., Lavalaye, J., de Bruin, K., de Clin.Neurosci. 256 Suppl 1, i3-11. Wolff, F.A., Koopmans, R.P., Stoof, J.C., den Heeten, G.J., 1999. Comparative in vivo study of iodine-

& 251 Appendix

Rutter, J.J., Gundlah, C., Auerbach, S.B., 1994. Increase Schmidt, H.D., Duman, R.S., 2007. The role of in extracellular serotonin produced by uptake neurotrophic factors in adult hippocampal inhibitors is enhanced after chronic treatment with neurogenesis, antidepressant treatments and fluoxetine. Neurosci.Lett. 171, 183-186. animal models of depressive-like behavior. Behav. Pharmacol. 18, 391-418. Sahay, A., Hen, R., 2007. Adult hippocampal neurogenesis in depression. Nat.Neurosci. 10, 1110- Schmitt, A., Benninghoff, J., Moessner, R., Rizzi, M., 1115. Paizanis, E., Doenitz, C., Gross, S., Hermann, M., Gritti, A., Lanfumey, L., Fritzen, S., Reif, A., Hamon, Sakaue, M., Somboonthum, P., Nishihara, B., Koyama, M., Murphy, D.L., Vescovi, A., Lesch, K.P., 2007. Adult Y., Hashimoto, H., Baba, A., Matsuda, T., 2000. neurogenesis in serotonin transporter deficient Postsynaptic 5-hydroxytryptamine(1A) receptor mice. J.Neural Transm. 114, 1107-1119. activation increases in vivo dopamine release in rat prefrontal cortex. Br.J.Pharmacol. 129, 1028-1034. Schouw, M.L., Gevers, S., Caan, M.W., Majoie, C.B., Booij, J., Nederveen, A.J., Reneman, L., 2012. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, Mapping serotonergic dysfunction in MDMA F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., (ecstasy) users using pharmacological MRI. Eur. Arancio, O., Belzung, C., Hen, R., 2003. Requirement Neuropsychopharmacol. 22, 537-545. of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809. Schule, C., 2007. Neuroendocrinological mechanisms of actions of antidepressant drugs. J.Neuroendocrinol. Sass, A., Wortwein, G., 2012. The effect of subchronic 19, 213-226. fluoxetine treatment on learning and memory in adolescent rats. Behav.Brain Res. 228, 169-175. Schwarz, A.J., Danckaert, A., Reese, T., Gozzi, A., Paxinos, G., Watson, C., Merlo-Pich, E.V., Bifone, A., Saulin, A., Savli, M., Lanzenberger, R., 2012. Serotonin 2006. A stereotaxic MRI template set for the rat brain and molecular neuroimaging in humans using PET. with tissue class distribution maps and co-registered Amino.Acids 42, 2039-2057. anatomical atlas: application to pharmacological Saylor, C.F., Finch, A.J., Jr., Spirito, A., Bennett, B., 1984. MRI. Neuroimage. 32, 538-550. The children’s depression inventory: a systematic Schwarz, A.J., Gozzi, A., Reese, T., Bifone, A., 2007. evaluation of psychometric properties. J.Consult In vivo mapping of functional connectivity in Clin.Psychol. 52, 955-967. neurotransmitter systems using pharmacological Scanley, B.E., Kennan, R.P., Gore, J.C., 2001. Changes MRI. NeuroImage 34, 1627-1636. in rat cerebral blood volume due to modulation of Seidman, L.J., Biederman, J., Liang, L., Valera, E.M., the 5-HT1A receptor measured with susceptibility Monuteaux, M.C., Brown, A., Kaiser, J., Spencer, enhanced contrast MRI. Brain Research 913, 149- T., Faraone, S.V., Makris, N., 2011. Gray matter 155. alterations in adults with attention-deficit/ Scheffel, U., Dannals, R.F., Cline, E.J., Ricaurte, G.A., hyperactivity disorder identified by voxel based Carroll, F.I., Abraham, P., Lewin, A.H., Kuhar, M.J., morphometry. Biol.Psychiatry 69, 857-866. 1992. [123/125I]RTI-55, an in vivo label for the Seifritz, E., Baumann, P., Muller, M.J., Annen, O., Amey, serotonin transporter. Synapse 11, 134-139. M., Hemmeter, U., Hatzinger, M., Chardon, F., Schirm, E., Tobi, H., de Jong-van den Berg LT, 2002. Holsboer-Trachsler, E., 1996. Neuroendocrine effects Unlicensed and off label drug use by children in the of a 20-mg citalopram infusion in healthy males. A community: cross sectional study. BMJ 324, 1312- placebo-controlled evaluation of citalopram as 5-HT 1313. function probe. Neuropsychopharmacology 14, 253- 263. Schmand, B., Bakker, D., Saan, R., Louman, J., 1991. [The Dutch Reading Test for Adults: a measure of Sekar, S., Verhoye, M., Van Audekerke, .J., Vanhoutte, G., premorbid intelligence level]. Tijdschr.Gerontol. Lowe, A.S., Blamire, A.M., Steckler, T., Van der Linden, Geriatr. 22, 15-19. A., Shoaib, M., 2011. Neuroadaptive responses to

252 References

citalopram in rats using pharmacological magnetic Shishkina, G.T., Kalinina, T.S., Dygalo, N.N., 2007. Up- resonance imaging. Psychopharmacology (Berl) 213, regulation of tryptophan hydroxylase-2 mRNA in the 521-531. rat brain by chronic fluoxetine treatment correlates with its antidepressant effect. Neuroscience 150, Serretti, A., Mandelli, L., Lorenzi, C., Pirovano, A., 404-412. Olgiati, P., Colombo, C., Smeraldi, E., 2007. Serotonin transporter gene influences the time course of Shrout, P.E., Fleiss, J.L., 1979. Intraclass correlations: improvement of “core” depressive and somatic uses in assessing rater reliability. Psychol.Bull. 86, anxiety symptoms during treatment with SSRIs for 420-428. recurrent mood disorders. Psychiatry Research 149, Silveri, M.M., Anderson, C.M., McNeil, J.F., Diaz, C.I., 185-193. Lukas, S.E., Mendelson, J.H., Renshaw, P.F., Kaufman, Shaffer, D., Fisher, P., Lucas, C.P., Dulcan, M.K., Schwab- M.J., 2004. Oral methylphenidate challenge Stone, M.E., 2000. NIMH Diagnostic Interview selectively decreases putaminal T2 in healthy Schedule for Children Version IV (NIMH DISC-IV): subjects. Drug Alcohol Depend. 76, 173-180. description, differences from previous versions, and Slotkin, T.A., McCook, E.C., Ritchie, J.C., Carroll, B.J., reliability of some common diagnoses. J.Am.Acad. Seidler, F.J., 1997. Serotonin transporter expression Child Adolesc.Psychiatry 39, 28-38. in rat brain regions and blood platelets: aging and Shaffer, D., Gould, M.S., Brasic, J., Ambrosini, P., Fisher, glucocorticoid effects. Biol.Psychiatry 41, 172-183. P., Bird, H., Aluwahlia, S., 1983. A children’s global Slotkin, T.A., Ryde, I.T., Levin, E.D., Seidler, F.J., 2008. assessment scale (CGAS). Arch.Gen.Psychiatry 40, Developmental neurotoxicity of low dose diazinon 1228-1231. exposure of neonatal rats: effects on serotonin Shah, Y.B., Marsden, C.A., 2004. The application systems in adolescence and adulthood. Brain Res. of functional magnetic resonance imaging Bull. 75, 640-647. to neuropharmacology. Current Opinion in Smith, E.E., Jonides, J., 1999. Storage and executive Pharmacology 4, 517-521. processes in the frontal lobes. Science 283, 1657- Sharp, T., 2010. Serotonergic Feedback Control. In: 1661. Müller, C.P., Jacobs, B.L. (Eds.), Handbook of the Smith, G.S., Ma, Y., Dhawan, V., Gunduz, H., Carbon, Behavioral Neurobiology of Serotonin, 1st ed ed. M., Kirshner, M., Larson, J., Chaly, T., Belakhleff, A., Academic Press, London, pp. 233-247. Kramer, E., Greenwald, B., Kane, J.M., Laghrissi- Shaw, P., Sharp, W.S., Morrison, M., Eckstrand, K., Thode, F., Pollock, B.G., Eidelber, D., 2002. Serotonin Greenstein, D.K., Clasen, L.S., Evans, A.C., Rapoport, modulation of cerebral glucose metabolism J.L., 2009. Psychostimulant treatment and the measured with positron emission tomography (PET) developing cortex in attention deficit hyperactivity in human subjects. Synapse 45, 105-112. disorder. Am.J.Psychiatry 166, 58-63. Smith, S.M., Jenkinson, M., Woolrich, M.W., Beckmann, Shemer, A.V., Azmitia, E.C., Whitaker-Azmitia, C.F., Behrens, T.E., Johansen-Berg, H., Bannister, P.M., 1991. Dose-related effects of prenatal P.R., De Luca, M., Drobnjak, I., Flitney, D.E., Niazy, 5-methoxytryptamine (5-MT) on development of R.K., Saunders, J., Vickers, J., Zhang, Y., De Stefano, serotonin terminal density and behavior. Brain Res. N., Brady, J.M., Matthews, P.M., 2004. Advances in Dev.Brain Res. 59, 59-63. functional and structural MR image analysis and implementation as FSL. NeuroImage 23 Suppl 1, Sherman, C.A., Higgins, G.A., 1992. Regulated splicing S208-S219. of the amyloid precursor protein gene during postnatal development of the rat basal forebrain. Soumier, A., Banasr, M., Goff, L.K., Daszuta, A., Brain Res.Dev.Brain Res. 66, 63-69. 2010. Region- and phase-dependent effects of 5-HT(1A) and 5-HT(2C) receptor activation on adult neurogenesis. Eur.Neuropsychopharmacol. 20, 336- 345. & 253 Appendix

Sowell, E.R., Delis, D., Stiles, J., Jernigan, T.L., 2001. Steward, C.A., Marsden, C.A., Prior, M.J., Morris, P.G., Improved memory functioning and frontal lobe Shah, Y.B., 2005. Methodological considerations maturation between childhood and adolescence: a in rat brain BOLD contrast pharmacological MRI. structural MRI study. J Int.Neuropsychol.Soc. 7, 312- Psychopharmacology (Berl) 180, 687-704. 322. Stranahan, A.M., Khalil, D., Gould, E., 2006. Social Sowell, E.R., Peterson, B.S., Thompson, P.M., Welcome, isolation delays the positive effects of running on S.E., Henkenius, A.L., Toga, A.W., 2003. Mapping adult neurogenesis. Nat.Neurosci. 9, 526-533. cortical change across the human life span. Nat. Strominger, J.L., 1947. The relation between water Neurosci 6, 309-315. intake and food intake in normal rats and in rats with Sowell, E.R., Thompson, P.M., Holmes, C.J., Batth, R., hypothalamic hyperphasia. Yale J.Biol.Med. 19, 279- Jernigan, T.L., Toga, A.W., 1999. Localizing age-related 288. changes in brain structure between childhood and Strupp, J.P., 1996. Stimulate: A GUI based fMRI Analysis adolescence using statistical parametric mapping. Software Package. 3 ed, p. S607. Neuroimage. 9, 587-597. Su, X.W., Li, X.Y., Banasr, M., Duman, R.S., 2009. Spear, L.P., 2000. The adolescent brain and age-related Eszopiclone and fluoxetine enhance the survival of behavioral manifestations. Neurosci Biobehav.Rev newborn neurons in the adult rat hippocampus. 24, 417-463. Int.J.Neuropsychopharmacol. 12, 1421-1428. Spencer, T.J., Biederman, J., Ciccone, P.E., Madras, B.K., Sui, Y., Zhang, Z., Guo, Y., Sun, Y., Zhang, X., Xie, C., Li, Dougherty, D.D., Bonab, A.A., Livni, E., Parasrampuria, Y., Xi, G., 2009. The function of Notch1 signaling D.A., Fischman, A.J., 2006. PET study examining was increased in parallel with neurogenesis in rat pharmacokinetics, detection and likeability, and hippocampus after chronic fluoxetine administration. dopamine transporter receptor occupancy of Biol.Pharm.Bull. 32, 1776-1782. short- and long-acting oral methylphenidate. Am.J.Psychiatry 163, 387-395. Surget, A., Tanti, A., Leonardo, E.D., Laugeray, A., Rainer, Q., Touma, C., Palme, R., Griebel, G., Ibarguen-Vargas, Spurlock, G., Buckland, P., O’Donovan, M., McGuffin, Y., Hen, R., Belzung, C., 2011. Antidepressants recruit P., 1994. Lack of effect of antidepressant drugs new neurons to improve stress response regulation. on the levels of mRNAs encoding serotonergic Mol.Psychiatry 16, 1177-1188. receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 33, 433-440. Surguladze, S.A., Young, A.W., Senior, C., Brebion, G., Travis, M.J., Phillips, M.L., 2004. Recognition Staiti, A.M., Morgane, P.J., Galler, J.R., Grivetti, J.Y., Bass, accuracy and response bias to happy and sad facial D.C., Mokler, D.J., 2011. A microdialysis study of the expressions in patients with major depression. medial prefrontal cortex of adolescent and adult Neuropsychology. 18, 212-218. rats. Neuropharmacology 61, 544-549. Suri, D., Veenit, V., Sarkar, A., Thiagarajan, D., Kumar, Stark, J.A., McKie, S., Davies, K.E., Williams, S.R., A., Nestler, E.J., Galande, S., Vaidya, V.A., 2013. Early Luckman, S.M., 2008. 5-HT(2C) antagonism blocks Stress Evokes Age-Dependent Biphasic Changes in blood oxygen level-dependent pharmacological- Hippocampal Neurogenesis, Bdnf Expression, and challenge magnetic resonance imaging signal in rat Cognition. Biol.Psychiatry. 73, 658–666. brain areas related to feeding. Eur.J.Neurosci. 27, 457-465. Swaab, D.F., Bao, A.M., Lucassen, P.J., 2005. The stress system in the human brain in depression and Stark, J.A., Davies, K.E., Williams, S.R., Luckman, S.M., neurodegeneration. Ageing Res.Rev. 4, 141-194. 2006. Functional magnetic resonance imaging and c-Fos mapping in rats following an anorectic dose of Swaab, D.F., Boer, K., 2001. Functional teratogenic m-chlorophenylpiperazine. NeuroImage 31, 1228- effects of chemicals on the developing brain. In: 1237. Levene, M.I., Whittle, M.J., Chervenak, F.A., Punt, J.,

254 References

Bennett, M.J. (Eds.), Fetal and Neonatal Neurology and deactivation responses to visual attention and Neurosurgery, 3rd ed. Churchill Livingstone, pp. and working memory tasks in healthy controls. 251-265. Neuroimage. 54, 3101-3110.

Swanson, J., 2003. Compliance with stimulants for Tordera, R.M., Monge, A., Del Rio, .J., Lasheras, B., attention-deficit/hyperactivity disorder: issues and 2002. Antidepressant-like activity of VN2222, a approaches for improvement. CNS.Drugs 17, 117- serotonin reuptake inhibitor with high affinity at 131. 5-HT1A receptors. Eur.J.Pharmacol. 442, 63-71.

Takahashi, H., Yahata, N., Koeda, M., Takano, A., Tordera, R.M., Pei, Q., Sharp, T., 2005. Evidence for Asai, K., Suhara, T., Okubo, Y., 2005. Effects of increased expression of the vesicular glutamate dopaminergic and serotonergic manipulation on transporter, VGLUT1, by a course of antidepressant emotional processing: a pharmacological fMRI study. treatment. J.Neurochem. 94, 875-883. Neuroimage. 27, 991-1001. Torres, G.E., Gainetdinov, R.R., Caron, M.G., 2003. Talairach, J., Tournoux, P., 1988. Co-planar stereotaxic Plasma membrane monoamine transporters: atlas of the human brain. Thieme, New York. structure, regulation and function. Nat.Rev.Neurosci. 4, 13-25. Tanda, G., Frau, R., Di Chiara, G., 1996. Chronic desipramine and fluoxetine differentially affect Tracey, I., 2001. Prospects for human pharmacological extracellular dopamine in the rat prefrontal cortex. functional magnetic resonance imaging (phMRI). Psychopharmacology (Berl) 127, 83-87. J.Clin.Pharmacol. Suppl, 21S-28S.

Tao, R., Calley, C.S., Hart, J., Mayes, T.L., Nakonezny, P.A., Vaidya, C.J., Austin, G., Kirkorian, G., Ridlehuber, H.W., Lu, H., Kennard, B.D., Tamminga, C.A., Emslie, G.J., Desmond, J.E., Glover, G.H., Gabrieli, J.D., 1998. 2012. Brain activity in adolescent major depressive Selective effects of methylphenidate in attention disorder before and after fluoxetine treatment. deficit hyperactivity disorder: a functional magnetic Am.J.Psychiatry 169, 381-388. resonance study. Proc.Natl.Acad.Sci.U.S.A 95, 14494-14499. Tardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., Popoli, M., 2006. Signaling pathways regulating van Dijk, C., Zuidgeest, M., van Dijk, L., Verheij, R., 2008. gene expression, neuroplasticity, and neurotrophic Huisartsenzorg in cijfers: stijging behandeling ADHD mechanisms in the action of antidepressants: a bij kinderen. Huisarts en Wetenschap 51, 641. critical overview. Pharmacol.Rev. 58, 115-134. van Dyck, C.H., Malison, R.T., Seibyl, J.P., Laruelle, M., Taupin, P., 2010. Adult neurogenesis and neural stem Klumpp, H., Zoghbi, S.S., Baldwin, R.M., Innis, R.B., cells as a model for the discovery and development 2000. Age-related decline in central serotonin of novel drugs. Expert.Opin.Drug Discov. 5, 921-925. transporter availability with [(123)I]beta-CIT SPECT. Neurobiol.Aging 21, 497-501. Taylor, D.P., 1990. Serotonin agents in anxiety. Ann.N.Y.Acad.Sci. 600, 545-556. van Vliet, I.M., de Beurs, E., 2007. [The MINI- International Neuropsychiatric Interview. A brief Tham, M.W., Woon, P.S., Sum, M.Y., Lee, T.S., structured diagnostic psychiatric interview for Sim, K., 2011. White matter abnormalities in DSM-IV en ICD-10 psychiatric disorders]. Tijdschr. major depression: evidence from post-mortem, Psychiatr. 49, 393-397. neuroimaging and genetic studies. J.Affect.Disord. 132, 26-36. Vitiello, B., 2003. Ethical considerations in psychopharmacological research involving children Toga, A.W., Thompson, P.M., Sowell, E.R., 2006. and adolescents. Psychopharmacology (Berl) 171, Mapping brain maturation. Trends Neurosci. 29, 86-91. 148-159. Vogel, C., Marcotte, E.M., 2012. Insights into the Tomasi, D., Volkow, N.D., Wang, G.J., Wang, R., Telang, regulation of protein abundance from proteomic F., Caparelli, E.C., Wong, C., Jayne, M., Fowler, J.S., and transcriptomic analyses. Nat.Rev.Genet. 13, 2011. Methylphenidate enhances brain activation 227-232. & 255 Appendix

Volkers, A.C., Heerdink, E.R., van Dijk, .L., 2007. Weintrob, N., Cohen, D., Klipper-Aurbach, Y., Zadik, Antidepressant use and off-label prescribing in Z., Dickerman, Z., 2002. Decreased Growth During children and adolescents in Dutch general practice Therapy With Selective Serotonin Reuptake (2001-2005). Pharmacoepidemiol.Drug Saf 16, 1054- Inhibitors. Archives of Pediatrics Adolescent 1062. Medicine 156, 696-701.

Vollm, B., Richardson, P., McKie, S., Elliott, R., Deakin, Whitaker-Azmitia, P.M., Druse, M., Walker, P., Lauder, J.F., Anderson, I.M., 2006. Serotonergic modulation J.M., 1996. Serotonin as a developmental signal. of neuronal responses to behavioural inhibition Behav.Brain Res. 73, 19-29. and reinforcing stimuli: an fMRI study in healthy Whitaker-Azmitia, P.M., Azmitia, E.C., 1989. Stimulation volunteers. Eur.J Neurosci 23, 552-560. of astroglial serotonin receptors produces culture von Frijtag, J.C., Schot, M., Van den Bos, R., Spruijt, media which regulates growth of serotonergic B.M., 2002. Individual housing during the play period neurons. Brain Research 497, 80-85. results in changed responses to and consequences Wijlaars, L.P., Nazareth, I., Petersen, I., 2012. Trends of a psychosocial stress situation in rats. Dev. in depression and antidepressant prescribing in Psychobiol. 41, 58-69. children and adolescents: a cohort study in The Vorhees, C.V., Morford, L.R., Graham, D.L., Skelton, Health Improvement Network (THIN). PLoS.ONE. 7, M.R., Williams, M.T., 2011. Effects of periadolescent e33181. fluoxetine and paroxetine on elevated plus-maze, Wilens, T.E., Biederman, J., Kwon, A., Chase, R., acoustic startle, and swimming immobility in rats Greenberg, L., Mick, E., Spencer, T.J., 2003. A while on and off-drug. Behav.Brain Funct. 7, 41. systematic chart review of the nature of psychiatric Wang, D.J., Chen, Y., Fernandez-Seara, M.A., Detre, J.A., adverse events in children and adolescents treated 2011a. Potentials and challenges for arterial spin with selective serotonin reuptake inhibitors. J.Child labeling in pharmacological magnetic resonance Adolesc.Psychopharmacol. 13, 143-152. imaging. J.Pharmacol.Exp.Ther. 337, 359-366. Wilens, T.E., Cohen, L., Biederman, J., Abrams, A., Wang, Y., Saykin, A.J., Pfeuffer, J., Lin, C., Mosier, K.M., Neft, D., Faird, N., Sinha, V., 2002. Fluoxetine Shen, L., Kim, S., Hutchins, G.D., 2011b. Regional pharmacokinetics in pediatric patients. J Clin reproducibility of pulsed arterial spin labeling Psychopharmacol. 22, 568-575. perfusion imaging at 3T. Neuroimage. 54, 1188- Willshire, D., Kinsella, G., Prior, M., 1991. Estimating 1195. WAIS-R IQ from the National Adult Reading Test: a Weber, R., Ramos-Cabrer, P., Wiedermann, D., van, C.N., cross-validation. J.Clin.Exp.Neuropsychol. 13, 204- Hoehn, M., 2006. A fully noninvasive and robust 216. experimental protocol for longitudinal fMRI studies Windischberger, C., Lanzenberger, R., Holik, A., in the rat. Neuroimage. 29, 1303-1310. Spindelegger, C., Stein, P., Moser, U., Gerstl, F., Webster, M.J., Weickert, C.S., Herman, M.M., Kleinman, Fink, M., Moser, E., Kasper, S., 2010. Area-specific J.E., 2002. BDNF mRNA expression during postnatal modulation of neural activation comparing development, maturation and aging of the human escitalopram and citalopram revealed by pharmaco- prefrontal cortex. Brain Res.Dev.Brain Res. 139, 139- fMRI: a randomized cross-over study. Neuroimage. 150. 49, 1161-1170.

Wegerer, V., Moll, G.H., Bagli, M., Rothenberger, A., Wohlfarth, T., Kalverdijk, L., Rademaker, C., Schothorst, Ruther, E., Huether, G., 1999. Persistently increased P., Minderaa, R., Gispen-de Wied, C., 2009. density of serotonin transporters in the frontal Psychopharmacology for children: from off label use cortex of rats treated with fluoxetine during early to registration. Eur.Neuropsychopharmacol. 19, 603- juvenile life. J.Child Adolesc.Psychopharmacol. 9, 608. 13-24.

256 References

Wohlfarth, T.D., van Zwieten, B.J., Lekkerkerker, F.J., Yetkin, F.Z., McAuliffe, T.L., Cox, R., Haughton, Gispen-de Wied, C.C., Ruis, J.R., Elferink, A.J., V.M., 1996. Test-retest precision of functional Storosum, J.G., 2006. Antidepressants use in MR in sensory and motor task activation. AJNR children and adolescents and the risk of suicide. Eur. Am.J.Neuroradiol. 17, 95-98. Neuropsychopharmacol. 16, 79-83. Yoon, S.Y., Jain, U., Shapiro, C., 2012. Sleep in attention- Wohlfarth, T., Lekkerkerker, F., van Zwieten, B., 2004. deficit/hyperactivity disorder in children and adults: Use of selective serotonin reuptake inhibitors in past, present, and future. Sleep Med.Rev. 16, 371- childhood depression. The Lancet 364, 659-660. 388.

Wolf, R.L., Detre, J.A., 2007. Clinical neuroimaging using Zhang, Z., Andersen, A.H., Ai, Y., Loveland, A., Hardy, arterial spin-labeled perfusion magnetic resonance P.A., Gerhardt, G.A., Gash, D.M., 2006. Assessing imaging. Neurotherapeutics. 4, 346-359. nigrostriatal dysfunctions by pharmacological MRI in parkinsonian rhesus macaques. Neuroimage. 33, Won, L., Bubula, N., Heller, A., 2002. Fetal exposure 636-643. to (+/-)-methylenedioxymethamphetamine in utero enhances the development and metabolism Zisook, S., Lesser, I., Stewart, J.W., Wisniewski, S.R., of serotonergic neurons in three-dimensional Balasubramani, G.K., Fava, M., Gilmer, W.S., reaggregate tissue culture. Brain Res.Dev.Brain Res. Dresselhaus, T.R., Thase, M.E., Nierenberg, A.A., 137, 67-73. Trivedi, M.H., Rush, A.J., 2007. Effect of age at onset on the course of major depressive disorder. Wong, D.T., Bymaster, F.P., Reid, L.R., Threlkeld, P.G., Am.J.Psychiatry 164, 1539-1546. 1983. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors. Zito, J.M., Safer, D.J., DosReis, S., Gardner, J.F., Soeken, Biochem.Pharmacol 32, 1287-1293. K., Boles, M., Lynch, F., 2002. Rising prevalence of antidepressants among US youths. Pediatrics 109, Woolrich, M.W., Jbabdi, S., Patenaude, B., Chappell, M., 721-727. Makni, S., Behrens, T., Beckmann, C., Jenkinson, M., Smith, S.M., 2009. Bayesian analysis of neuroimaging Zito, J.M., Tobi, H., de Jong-van den Berg LT, Fegert, data in FSL. NeuroImage 45, S173-S186. J.M., Safer, D.J., Janhsen, K., Hansen, D.G., Gardner, J.F., Glaeske, G., 2006. Antidepressant Woolsey, T.A., Welker, C., Schwartz, R.H., 1975. prevalence for youths: a multi-national comparison. Comparative anatomical studies of the SmL face Pharmacoepidemiol.Drug Saf 15, 793-798. cortex with special reference to the occurrence of “barrels” in layer IV. J.Comp Neurol. 164, 79-94.

World Health Organization, 1990. Composite International Diagnostic Interview. World Health Organization, Geneva, Switserland.

Worsley, K.J., 2001. Statistical analysis of activation images. In: Jezzard, P., Matthews, P.M., Smith, S.M. (Eds.), Functional MRI: An Introduction to Methods. OUP.

Yan, W., Wilson, C.C., Haring, J.H., 1997. 5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells. Brain Res.Dev.Brain Res. 98, 185-190.

Yen, T.T., Fuller, R.W., 1992. Preclinical pharmacology of fluoxetine, a serotonergic drug for weight loss. Am.J.Clin.Nutr. 55, 177S-180S.

& 257